# EDGAR Filing Document

**Accession Number:** 0000918965
**File Stem:** 0000918965-25-000045
**Filing Date:** 2025-11
**Character Count:** 212415
**Document Hash:** 65cbf834df1aa839c8f5572c5479d95a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000918965-25-000045.hdr.sgml**: 20251106

**ACCESSION NUMBER**: 0000918965-25-000045

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 104

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251106

**DATE AS OF CHANGE**: 20251106

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SCANSOURCE, INC.
- **CENTRAL INDEX KEY:** 0000918965
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-COMPUTER & PERIPHERAL EQUIPMENT & SOFTWARE [5045]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 570965380
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-26926
- **FILM NUMBER:** 251456373

**BUSINESS ADDRESS:**
- **STREET 1:** 6 LOGUE COURT
- **CITY:** GREENVILLE
- **STATE:** SC
- **ZIP:** 29615
- **BUSINESS PHONE:** 800.944.2432

**MAIL ADDRESS:**
- **STREET 1:** 6 LOGUE COURT
- **CITY:** GREENVILLE
- **STATE:** SC
- **ZIP:** 29615

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SCANSOURCE INC
- **DATE OF NAME CHANGE:** 19940214

?xml version='1.0' encoding='ASCII'? scsc-20250930

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

 

**FORM 10-Q**

 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from ____ to ____**

**Commission File Number: 000-26926**

 

![scansourcelogo4a291a06.jpg](scsc-20250930_g1.jpg)

---

| | | |
|:---|:---|:---|
| | **ScanSource, Inc.** | |
| (Exact name of registrant as specified in its charter) | (Exact name of registrant as specified in its charter) | (Exact name of registrant as specified in its charter) |
| **South Carolina** |  | **57-0965380** |
| (State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.) |
| **6 Logue Court** |  | **29615** |
| **Greenville, South Carolina** |  | (Zip Code) |
| (Address of principal executive offices) |  |  |

---

**(864) 288-2432** 

**(Registrant's telephone number, including area code)**

_______________________________________________

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of Each Class** | **Trading Symbol** | **Name of Each Exchange on Which Registered** |
| **Common Stock, no par value** | **SCSC** | **NASDAQ Global Select Market** |

---

**Securities registered pursuant to Section 12(g) of the Act:**

**None.**

_______________________________________________

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

------

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Smaller reporting company | ☐ |
| Accelerated filer | ☐ | Emerging growth company | ☐ |
| Non-accelerated filer | ☐ | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

---

| | |
|:---|:---|
| **Class** | **Outstanding at November 3, 2025** |
| **Common Stock, no par value per share** | **21,942,503 shares** |

---

------

**SCANSOURCE, INC.**

**INDEX TO FORM 10-Q**

**September 30, 2025** 

---

| | | |
|:---|:---|:---|
| | | **Page #** |
| **<u>[PART I. FINANCIAL INFORMATION](#i46704b41bb0b4774b71bf1ae9cea5ff2_13)</u>** | **<u>[PART I. FINANCIAL INFORMATION](#i46704b41bb0b4774b71bf1ae9cea5ff2_13)</u>** | |
| &nbsp;&nbsp;Item 1. | <u>Financial Statements</u> | <u>[5](#i46704b41bb0b4774b71bf1ae9cea5ff2_16)</u> |
|  | <u>[Condensed Consolidated Balance Sheets (unaudited) at](#i46704b41bb0b4774b71bf1ae9cea5ff2_19)[September 30](#i46704b41bb0b4774b71bf1ae9cea5ff2_19)[, 2025 and June 30, 20](#i46704b41bb0b4774b71bf1ae9cea5ff2_19)[25](#i46704b41bb0b4774b71bf1ae9cea5ff2_19)</u> | <u>[5](#i46704b41bb0b4774b71bf1ae9cea5ff2_19)</u> |
|  | <u>[Condensed Consolidated Income Statements (unaudited) for the Quarters](#i46704b41bb0b4774b71bf1ae9cea5ff2_22)[ended](#i46704b41bb0b4774b71bf1ae9cea5ff2_22)[September 30](#i46704b41bb0b4774b71bf1ae9cea5ff2_22)[, 2025 and 2024](#i46704b41bb0b4774b71bf1ae9cea5ff2_22)</u> | <u>[6](#i46704b41bb0b4774b71bf1ae9cea5ff2_22)</u> |
|  | <u>[Condensed Consolidated Statements of Comprehensive Income (unaudited) for the Quarters](#i46704b41bb0b4774b71bf1ae9cea5ff2_25)[ended](#i46704b41bb0b4774b71bf1ae9cea5ff2_25)[September](#i46704b41bb0b4774b71bf1ae9cea5ff2_25)[30](#i46704b41bb0b4774b71bf1ae9cea5ff2_25)[, 2025 and 2024](#i46704b41bb0b4774b71bf1ae9cea5ff2_25)</u> | <u>[7](#i46704b41bb0b4774b71bf1ae9cea5ff2_25)</u> |
|  | <u>[Condensed Consolidated Statements of Shareholders' Equity (unaudited) for the Quarters](#i46704b41bb0b4774b71bf1ae9cea5ff2_28)[ended](#i46704b41bb0b4774b71bf1ae9cea5ff2_28)[September](#i46704b41bb0b4774b71bf1ae9cea5ff2_28)[30](#i46704b41bb0b4774b71bf1ae9cea5ff2_28)[, 2025 and 2024](#i46704b41bb0b4774b71bf1ae9cea5ff2_28)</u> | <u>[8](#i46704b41bb0b4774b71bf1ae9cea5ff2_28)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows (unaudited) for the](#i46704b41bb0b4774b71bf1ae9cea5ff2_31)[Three](#i46704b41bb0b4774b71bf1ae9cea5ff2_31)[Months Ended](#i46704b41bb0b4774b71bf1ae9cea5ff2_31)[September](#i46704b41bb0b4774b71bf1ae9cea5ff2_31)[30](#i46704b41bb0b4774b71bf1ae9cea5ff2_31)[, 2025 and 2024](#i46704b41bb0b4774b71bf1ae9cea5ff2_31)</u> | <u>[10](#i46704b41bb0b4774b71bf1ae9cea5ff2_31)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements (unaudited)](#i46704b41bb0b4774b71bf1ae9cea5ff2_34)</u> | <u>[11](#i46704b41bb0b4774b71bf1ae9cea5ff2_34)</u> |
| &nbsp;&nbsp;Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i46704b41bb0b4774b71bf1ae9cea5ff2_88)</u> | <u>[27](#i46704b41bb0b4774b71bf1ae9cea5ff2_88)</u> |
| &nbsp;&nbsp;Item 3. | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i46704b41bb0b4774b71bf1ae9cea5ff2_166)</u> | <u>[42](#i46704b41bb0b4774b71bf1ae9cea5ff2_166)</u> |
| &nbsp;&nbsp;Item 4. | <u>[Controls and Procedures](#i46704b41bb0b4774b71bf1ae9cea5ff2_169)</u> | <u>[43](#i46704b41bb0b4774b71bf1ae9cea5ff2_169)</u> |
| **<u>[PART II. OTHER INFORMATION](#i46704b41bb0b4774b71bf1ae9cea5ff2_172)</u>** | **<u>[PART II. OTHER INFORMATION](#i46704b41bb0b4774b71bf1ae9cea5ff2_172)</u>** |  |
| &nbsp;&nbsp;Item 1. | <u>[Legal Proceedings](#i46704b41bb0b4774b71bf1ae9cea5ff2_175)</u> | <u>[44](#i46704b41bb0b4774b71bf1ae9cea5ff2_175)</u> |
| &nbsp;&nbsp;Item 1A. | <u>[Risk Factors](#i46704b41bb0b4774b71bf1ae9cea5ff2_178)</u> | <u>[44](#i46704b41bb0b4774b71bf1ae9cea5ff2_178)</u> |
| &nbsp;&nbsp;Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i46704b41bb0b4774b71bf1ae9cea5ff2_181)</u> | <u>[44](#i46704b41bb0b4774b71bf1ae9cea5ff2_181)</u> |
| &nbsp;&nbsp;Item 5. | <u>[Other Information](#i46704b41bb0b4774b71bf1ae9cea5ff2_184)</u> | <u>[45](#i46704b41bb0b4774b71bf1ae9cea5ff2_184)</u> |
| &nbsp;&nbsp;Item 6. | <u>[Exhibits](#i46704b41bb0b4774b71bf1ae9cea5ff2_190)</u> | <u>[46](#i46704b41bb0b4774b71bf1ae9cea5ff2_190)</u> |
| **<u>[SIGNATURES](#i46704b41bb0b4774b71bf1ae9cea5ff2_193)</u>** | **<u>[SIGNATURES](#i46704b41bb0b4774b71bf1ae9cea5ff2_193)</u>** | <u>[47](#i46704b41bb0b4774b71bf1ae9cea5ff2_193)</u> |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**FORWARD-LOOKING STATEMENTS**

Forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act") included in the "Risk Factors," "Legal Proceedings," "Management's Discussion and Analysis of Financial Condition and Results of Operations," and "Quantitative and Qualitative Disclosures About Market Risk" sections and elsewhere herein. Words such as "expects," "anticipates," "believes," "intends," "plans," "hopes," "forecasts," "seeks," "estimates," "goals," "projects," "strategy," "future," "likely," "may," "should," "will," and variations of such words and similar expressions generally identify such forward-looking statements. Any forward-looking statement made by us in this Form 10-Q is based only on information currently available to us and speaks only as of the date on which it is made. Except as may be required by law, we expressly disclaim any obligation to update these forward-looking statements to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond our control. You should not place undue reliance on forward-looking statements as actual results could differ materially from those anticipated in these forward-looking statements as a result of a number of factors including, but not limited to the following factors, which are neither presented in order of importance nor weighted: macroeconomic conditions, including potential prolonged economic weakness, inflation and supply chain challenges, tariffs and changes in trade policy, the failure to manage and implement the Company's growth strategy, the Company's ability to realize the synergies or other benefits from acquisitions, credit risks involving the Company's larger channel sales partners and suppliers, changes in interest and exchange rates and regulatory regimes impacting the Company's international operations, including new or increased tariffs, risk to the Company's business from a cyber attack, a failure of the Company's IT systems, failure to hire and retain quality employees, loss of the Company's major channel sales partners, relationships with the Company's key suppliers and channel sales partners or a termination or a significant modification of the terms under which it operates with such suppliers and channel sales partners, changes in the Company's operating strategy and other factors set forth in "Risk Factors" contained in our Annual Report on Form 10-K for the year ended June 30, 2025.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**PART I. FINANCIAL INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Financial Statements** |

---

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)**

**(In thousands, except share information)** 

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **June 30, 2025** |
| <u>Assets</u> |  |  |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $**124924** | $126157 |
| &nbsp;&nbsp;Accounts receivable, less allowance of $29,226 at September 30, 2025<br>and $27,821 at June 30, 2025 | **557071** | 635521 |
| &nbsp;&nbsp;&nbsp;Inventories | **505339** | 483815 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | **120001** | 124959 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | **1307335** | 1370452 |
| Property and equipment, net | **32221** | 31169 |
| Goodwill | **231132** | 230820 |
| Identifiable intangible assets, net | **58510** | 62909 |
| Deferred income taxes | **16715** | 18769 |
| Other non-current assets | **71063** | 71487 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**1716976** | $1785606 |
| <u>Liabilities and Shareholders' Equity</u> |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $**529578** | $598595 |
| &nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | **63373** | 71263 |
| &nbsp;&nbsp;&nbsp;Current portion of contingent consideration | **1784** | 1318 |
| &nbsp;&nbsp;&nbsp;Income taxes payable | **3557** | 3927 |
| &nbsp;&nbsp;&nbsp;Current portion of long-term debt | **7866** | 7861 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | **606158** | 682964 |
| Long-term debt, net of current portion | **126047** | 128288 |
| Long-term portion of contingent consideration | **16255** | 17782 |
| Other long-term liabilities | **54484** | 50163 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | **802944** | 879197 |
| Commitments and contingencies |  |  |
| Shareholders' equity: |  |  |
| &nbsp;&nbsp;Preferred stock, no par value; 3,000,000 shares authorized, none issued | **—** |  |
| &nbsp;&nbsp;Common stock, no par value; 45,000,000 shares authorized, 22,067,128 and 22,217,421 shares issued and outstanding at September 30, 2025 and June 30, 2025, respectively | **—** |  |
| &nbsp;&nbsp;&nbsp;Retained earnings | **1024720** | 1020833 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | **(110688)** | (114424) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | **914032** | 906409 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $**1716976** | $1785606 |
| June 30, 2025 amounts are derived from audited consolidated financial statements. | June 30, 2025 amounts are derived from audited consolidated financial statements. | June 30, 2025 amounts are derived from audited consolidated financial statements. |
| See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED INCOME STATEMENTS (UNAUDITED)**

**(In thousands, except per share data)**

---

| | | |
|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
| Net sales | $**739650** | $775580 |
| Cost of goods sold | **632177** | 673961 |
| &nbsp;&nbsp;&nbsp;Gross profit | **107473** | 101619 |
| Selling, general and administrative expenses | **75275** | 71706 |
| Depreciation expense | **1577** | 2857 |
| Intangible amortization expense | **4404** | 4358 |
| Restructuring expense | **—** | 5068 |
| Change in fair value of contingent consideration | **314** |  |
| &nbsp;&nbsp;&nbsp;Operating income | **25903** | 17630 |
| Interest expense | **1914** | 2109 |
| Interest income | **(3180)** | (2659) |
| Other (income) expense, net | **173** | (4782) |
| &nbsp;&nbsp;&nbsp;Income before income taxes | **26996** | 22962 |
| Provision for income taxes | **7118** | 5988 |
| Net income | $**19878** | $16974 |
| Per share data: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per common share, basic | $**0.90** | $0.70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares outstanding, basic | **22018** | 24147 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per common share, diluted | $**0.89** | $0.69 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares outstanding, diluted | **22405** | 24646 |

---

See accompanying notes to these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)**

**(In thousands)**

---

| | | |
|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
| Net income | $**19878** | $16974 |
| Unrealized loss on hedged transaction, net of tax | **(230)** | (1050) |
| Foreign currency translation adjustment | **3966** | 4109 |
| &nbsp;&nbsp;Comprehensive income | $**23614** | $20033 |

---

See accompanying notes to these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)**

**(In thousands, except share information)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common<br>Stock<br>(Shares)** | **Common<br>Stock<br>(Amount)** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total** |
| Balance at June 30, 2025 | 22217421 | $— | $1020833 | $(114424) | $906409 |
| &nbsp;&nbsp;&nbsp;Net income | **—** | **—** | **19878** | **—** | **19878** |
| &nbsp;&nbsp;&nbsp;Unrealized loss on hedged transaction, net of tax | **—** | **—** | **—** | **(230)** | **(230)** |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | **—** | **—** | **—** | **3966** | **3966** |
| &nbsp;&nbsp;&nbsp;Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | **339444** | **2218** | **—** | **—** | **2218** |
| &nbsp;&nbsp;&nbsp;Common stock repurchased, including excise tax | **(489737)** | **(5094)** | **(15991)** | **—** | **(21085)** |
| &nbsp;&nbsp;&nbsp;Share-based compensation | **—** | **2876** | **—** | **—** | **2876** |
| Balance at September 30, 2025 | **22067128** | $**—** | $**1024720** | $**(110688)** | $**914032** |
| See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED)**

**(In thousands, except share information)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Common<br>Stock<br>(Shares)** | **Common<br>Stock<br>(Amount)** | **Retained<br>Earnings** | **Accumulated<br>Other<br>Comprehensive<br>Loss** | **Total** |
| Balance at June 30, 2024 | 24243848 | $26370 | $1013738 | $(115853) | $924255 |
| &nbsp;&nbsp;&nbsp;Net income |  |  | 16974 |  | 16974 |
| &nbsp;&nbsp;&nbsp;Unrealized loss on hedged transaction, net of tax |  |  |  | (1050) | (1050) |
| &nbsp;&nbsp;&nbsp;Foreign currency translation adjustment |  |  |  | 4109 | 4109 |
| &nbsp;&nbsp;&nbsp;Exercise of stock options and shares issued under share-based compensation plans, net of shares withheld for employee taxes | 349277 | 2177 |  |  | 2177 |
| &nbsp;&nbsp;&nbsp;Common stock repurchased, including excise tax | (588018) | (28043) |  |  | (28043) |
| &nbsp;&nbsp;&nbsp;Share-based compensation |  | 2471 |  |  | 2471 |
| Balance at September 30, 2024 | 24005107 | $2975 | $1030712 | $(112794) | $920893 |
| See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

 **SCANSOURCE, INC. AND SUBSIDIARIES**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)**

**(In thousands)**

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Net income | $**19878** | $16974 |
| &nbsp;&nbsp;&nbsp;Net income from continuing operations | **19878** | 16974 |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **6200** | 7471 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt issue costs | **96** | 96 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for doubtful accounts | **1928** | 1678 |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | **2876** | 2471 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **2079** | 2433 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **314** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Finance lease interest | **15** | 25 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | **79010** | 20606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | **(20574)** | 9524 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | **5262** | (1952) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-current assets | **552** | 3285 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | **(70297)** | (17002) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | **(3758)** | 744 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | **(370)** | (1523) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | **23211** | 44830 |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Capital expenditures | **(2395)** | (2375) |
| &nbsp;&nbsp;&nbsp;Cash paid for business acquisitions, net of cash acquired | **—** | (56849) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | **(2395)** | (59224) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Borrowings on revolving credit | **49210** | 8381 |
| &nbsp;&nbsp;&nbsp;Repayments on revolving credit | **(49210)** | (8430) |
| &nbsp;&nbsp;&nbsp;Repayments on long-term debt | **(2236)** | (357) |
| &nbsp;&nbsp;&nbsp;Repayments on finance lease obligation | **(271)** | (275) |
| &nbsp;&nbsp;&nbsp;Contingent consideration payments | **(1375)** |  |
| &nbsp;&nbsp;&nbsp;Exercise of stock options | **4834** | 6971 |
| &nbsp;&nbsp;&nbsp;Taxes paid on settlement of equity awards | **(2617)** | (4794) |
| &nbsp;&nbsp;&nbsp;Common stock repurchased, including excise tax | **(21285)** | (28126) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in financing activities | **(22950)** | (26630) |
| Effect of exchange rate changes on cash and cash equivalents | **901** | 608 |
| Decrease in cash and cash equivalents | **(1233)** | (40416) |
| Cash and cash equivalents at beginning of period | **126157** | 185460 |
| Cash and cash equivalents at end of period | $**124924** | $145044 |
| See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. | See accompanying notes to these condensed consolidated financial statements. |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**SCANSOURCE, INC. AND SUBSIDIARIES**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**(1) Business and Summary of Significant Accounting Policies**

*Business Description*

ScanSource, Inc. (together with its subsidiaries referred to as "the Company" or "ScanSource") is a leading technology distributor connecting devices to the cloud and accelerating growth for channel sales partners across hardware, software as a service ("SaaS"), connectivity and cloud services. ScanSource uses multiple sales models to offer technology distribution solutions from leading suppliers of specialty technologies and connectivity and cloud services. The Company operates primarily in the United States and Brazil. The Company's two operating segments, Specialty Technology Solutions and Intelisys & Advisory, represent the different sales models the Company uses in executing its technology distribution growth strategy.

*Basis of Presentation*

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared by the Company's management in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial information and applicable rules and regulations of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. The unaudited condensed consolidated financial statements included herein contain all adjustments (consisting of normal recurring and non-recurring adjustments) that are, in the opinion of management, necessary to present fairly the financial position at September 30, 2025 and June 30, 2025, the results of operations for the quarters ended September 30, 2025 and 2024, the condensed consolidated statements of comprehensive income for the quarters ended September 30, 2025 and 2024, the condensed consolidated statements of shareholders' equity for the quarters ended September 30, 2025 and 2024 and the condensed consolidated statements of cash flows for the three months ended September 30, 2025 and 2024. The results of operations for the quarters ended September 30, 2025 are not necessarily indicative of the results to be expected for a full year. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

*Summary of Significant Accounting Policies*

There have been no material changes to the Company's significant accounting policies for the quarter ended September 30, 2025 from the policies described in the notes to the Company's consolidated financial statements included in the Annual Report on Form 10-K for the fiscal year ended June 30, 2025. For a discussion of the Company's significant accounting policies, please see the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

*Cash and Cash Equivalents*

The Company considers all highly-liquid investments with original maturities of three months or less, when purchased, to be cash equivalents. The Company maintains zero-balance disbursement accounts at various financial institutions at which the Company does not maintain significant depository relationships. Due to the terms of the agreements governing these accounts, the Company generally does not have the right to offset outstanding checks written from these accounts against cash on hand, and the respective institutions are not legally obligated to honor the checks until sufficient funds are transferred to fund the checks. As a result, checks released but not yet cleared from these accounts were approximately $0.1 million and are included in accounts payable on the condensed consolidated balance sheets at September 30, 2025 and June 30, 2025.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

*Long-lived Assets*

The Company presents depreciation expense and intangible amortization expense on the condensed consolidated income statements. The Company's depreciation expense related to selling, general and administrative costs totaled $1.6 million and $2.9 million for the quarters ended September 30, 2025 and September 30, 2024, respectively. Depreciation expense reported as part of cost of goods sold on the condensed consolidated income statements totaled $0.2 million and $0.3 million for the quarters ended September 30, 2025 and September 30, 2024, respectively. The Company's intangible amortization expense reported on the condensed consolidated income statements relates to selling, general and administrative costs, not the cost of selling goods. Intangible amortization expense totaled $4.4 million for the quarters ended September 30, 2025 and September 30, 2024.

*Recent Accounting Pronouncements*

In December 2023, the FASB issued ASU No. 2023-09 "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." This ASU updates income tax disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. This ASU is effective for annual periods beginning after December 15, 2024 and is applicable to the Company's fiscal year beginning July 1, 2025, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.

In November 2024, the FASB issued ASU 2024-03 "Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses." This ASU requires public entities to disclose specified information about certain costs and expenses. The ASU is effective for annual periods beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027. This ASU is applicable to the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2027, and subsequent interim periods, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.

In September 2025, the FASB issued ASU 2025-06 "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." This standard is intended to improve the operability and application of guidance related to capitalized software development costs. The ASU is effective for annual reporting periods beginning after December 15, 2027, and subsequent interim periods, with early application permitted. The Company is currently evaluating the impact of the application of this ASU on its consolidated financial statements and disclosures.

The Company has reviewed other newly issued accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on its consolidated financial statements as a result of future adoption.

**(2) Trade Accounts and Notes Receivable, Net**

The Company maintains an allowance for doubtful accounts receivable for estimated future expected credit losses resulting from channel sales partners' failure to make payments on accounts receivable due to the Company. The Company has notes receivable with certain channel sales partners, which are included in "Accounts receivable, less allowance" in the Condensed Consolidated Balance Sheets.

Management determines the estimate of the allowance for doubtful accounts receivable by considering a number of factors, including: (i) historical experience, (ii) aging of the accounts receivable, (iii) specific information obtained by the Company on the financial condition and the current creditworthiness of its channel sales partners, (iv) the current economic and country-specific environment and (v) reasonable and supportable forecasts about collectability. Expected credit losses are estimated on a pool basis when similar risk characteristics exist using an age-based reserve model. Receivables that do not share risk characteristics are evaluated on an individual basis. Estimates of expected credit losses on trade receivables over the contractual life are recorded at inception and adjusted over the contractual life.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

The changes in the allowance for doubtful accounts for the three months ended September 30, 2025 are set forth in the table below.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **June 30, 2025** | **Amounts Charged to Expense** | **Write-offs** | **Other** <sup>(1)</sup> | **September 30, 2025** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Trade accounts and current notes receivable allowance | $**27821** | $**1928** | $**(743)** | $**220** | $**29226** |

---

<sup>(1)</sup> "Other" amounts include recoveries and the effect of foreign currency fluctuations for the three months ended September 30, 2025.

**(3) Revenue Recognition**

The Company provides technology solutions and services from the world's leading suppliers of mobility and barcode, POS, payment terminals, physical security, networking communications, connectivity and cloud services. This includes hardware, related accessories and device configuration as well as software licenses, professional services and hardware support programs.

In determining the appropriate amount of revenue to recognize, the Company applies the following five-step model in accordance with ASC 606: (i) identify contracts with customers; (ii) identify performance obligations in the contracts; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations per the contracts; and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company recognizes revenue as control of products and services are transferred to customers, which is generally at the point of shipment. The Company delivers products to customers in several ways, including: (i) shipment from a Company warehouse, (ii) drop-shipment directly from the supplier, or (iii) electronic delivery for non-physical products.

*Principal versus Agent Considerations*

The Company is the principal for sales of all hardware and certain software and services. The Company considers itself the principal in those transactions where it has control of the product or service before it is transferred to the customer. The Company recognizes the principal-associated revenue and cost of goods sold on a gross basis.

The Company is the agent for third-party service contracts, including product warranties and supplier-hosted software. These service contracts are sold separately from the products, and the Company often serves as the agent for the contract on behalf of the original equipment manufacturer. The Company's responsibility is to arrange for the provision of the specified service by the original equipment manufacturer, and the Company does not control the specified service before it is transferred to the customer. Because the Company acts as an agent, revenue is recognized net of cost at the time of sale. The Intelisys business operates under an agency model.

*Variable Considerations*

For certain transactions, products are sold with a right of return and may also provide other rebates or incentives, which are accounted for as variable consideration. The Company estimates a returns allowance based on historical experience and reduces revenue accordingly. The Company estimates the amount of variable consideration for rebates and incentives by using the expected value to be given to the customer and reduces the revenue by those estimated amounts. These estimates are reviewed and updated as necessary at the end of each reporting period.

*Contract Balances*

The Company records contract assets for services performed in advance of payments being received from channel sales partners. The Company records contract liabilities for payments received from channel sales partners in advance of services performed. These assets and liabilities are the result of the sales of the Company's self-branded warranty programs and other transactions where control has not yet passed to the customer. These amounts are immaterial to the consolidated financial statements for the periods presented.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

*Disaggregation of Revenue*

The following tables represent the Company's disaggregation of revenue:

---

| | | | |
|:---|:---|:---|:---|
| | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** |
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | | ***(in thousands)*** | |
| Revenue by product/service |  |  |  |
| &nbsp;&nbsp;&nbsp;Products and services | $**701631** | $**1353** | $**702984** |
| &nbsp;&nbsp;Recurring revenue<sup>(a)</sup> | **13816** | **22850** | **36666** |
|  | $**715447** | $**24203** | $**739650** |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** |
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | | ***(in thousands)*** | |
| Revenue by product/service |  |  |  |
| &nbsp;&nbsp;&nbsp;Products and services | $740644 | $974 | $741618 |
| &nbsp;&nbsp;Recurring revenue<sup>(a)</sup> | 11655 | 22307 | 33962 |
|  | $752299 | $23281 | $775580 |
| (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. | (a) Recurring revenue represents revenue primarily from agency commissions, managed connectivity, SaaS, subscriptions, and hardware rentals. |

---

**(4) Earnings Per Share**

Basic earnings per share are computed by dividing net income by the weighted-average number of common shares outstanding. Diluted earnings per share are computed by dividing net income by the weighted-average number of common and potential common shares outstanding.

---

| | | |
|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** |
| Numerator: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $**19878** | $16974 |
| Denominator: |  |  |
| &nbsp;&nbsp;Weighted-average shares, basic | **22018** | 24147 |
| &nbsp;&nbsp;Dilutive effect of share-based payments | **387** | 499 |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average shares, diluted | **22405** | 24646 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per common share, basic | $**0.90** | $0.70 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income per common share, diluted | $**0.89** | $0.69 |

---

For the quarters ended September 30, 2025 and 2024, weighted-average shares outstanding excluded from the computation of diluted earnings per share because their effect would be anti-dilutive were 295,562 and 109,450, respectively.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**(5) Accumulated Other Comprehensive Loss**

The components of accumulated other comprehensive loss, net of tax are as follows:

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **June 30, 2025** |
| | ***(in thousands)*** | ***(in thousands)*** |
| Foreign currency translation adjustment | $**(110968)** | $(114934) |
| Unrealized gain on hedged transaction, net of tax | **280** | 510 |
| &nbsp;&nbsp;Accumulated other comprehensive loss | $**(110688)** | $(114424) |

---

The tax effect of amounts in comprehensive loss reflect a tax benefit as follows:

---

| | | |
|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| Tax benefit | $**(45)** | $(363) |

---

**(6) Goodwill and Other Identifiable Intangible Assets**

The changes in the carrying amount of goodwill for the three months ended September 30, 2025, by reporting segment, are set forth in the table below.

---

| | | | |
|:---|:---|:---|:---|
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Balance at June 30, 2025 | $159779 | $71041 | $230820 |
| &nbsp;&nbsp;Foreign currency translation adjustment | 317 | (5) | 312 |
| Balance at September 30, 2025 | $**160096** | $**71036** | $**231132** |

---

The following table shows changes in the amount recognized for net identifiable intangible assets for the three months ended September 30, 2025.

---

| | |
|:---|:---|
| | **Net Identifiable Intangible Assets** |
| | ***(in thousands)*** |
| Balance at June 30, 2025 | $62909 |
| &nbsp;&nbsp;Amortization expense | (4404) |
| &nbsp;&nbsp;Foreign currency translation adjustment | 5 |
| Balance at September 30, 2025 | $**58510** |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**(7) Short-Term Borrowings and Long-Term Debt**

The following table presents the Company's debt at September 30, 2025 and June 30, 2025.

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **June 30, 2025** |
| | ***(in thousands)*** | ***(in thousands)*** |
| Current portion of long-term debt | $**7866** | $7861 |
| Mississippi revenue bond, net of current portion | **2297** | 2663 |
| Senior secured term loan facility, net of current portion | **123750** | 125625 |
| Borrowings under revolving credit facility | **—** |  |
| &nbsp;&nbsp;Total debt | $**133913** | $136149 |

---

*Credit Facility*

The Company has a multi-currency senior secured credit facility (as amended, the "Amended Credit Agreement") with JPMorgan Chase Bank N.A., as administrative agent (the "Administrative Agent"), and a syndicate of banks (collectively the "Lenders"). On September 28, 2022, the Company amended and restated the Amended Credit Agreement, which includes (i) a five-year, $350 million multicurrency senior secured revolving credit facility and (ii) a five-year $150 million senior secured term loan facility. The Amended Credit Agreement extended the credit facility maturity date to September 28, 2027. In addition, pursuant to an "accordion feature," the Company may increase its borrowing limit by up to an additional $250 million, subject to obtaining additional credit commitments from the lenders participating in the increase. The Amended Credit Agreement allows for the issuance of up to $50 million for letters of credit. Borrowings under the Amended Credit Agreement are guaranteed by substantially all of the domestic subsidiaries of the Company and secured by their assets. Under the terms of the revolving credit facility, the payment of cash dividends is restricted. The Company incurred debt issuance costs of $1.4 million in connection with the amendment and restatement of the Amended Credit Agreement. These costs were capitalized to other non-current assets on the Condensed Consolidated Balance Sheets and added to the unamortized debt issuance costs from the previous credit facility.

Loans denominated in U.S. dollars, other than swingline loans, bear interest at a rate per annum equal to, at the Company's option, (i) the adjusted term Secured Overnight Financing Rate ("SOFR") or adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon the Company's ratio of (A) total consolidated debt less up to $30 million of unrestricted domestic cash to (B) trailing four-quarter consolidated EBITDA measured as of the end of the most recent year or quarter, as applicable, for which financial statements have been delivered to the Lenders (the "leverage ratio"); or (ii) the alternate base rate plus an additional margin ranging from 0% to 0.75%, depending upon the Company's leverage ratio, plus, if applicable, certain mandatory costs. All swingline loans denominated in U.S. dollars bear interest based upon the adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon the Company's leverage ratio, or such other rate as the Company and the applicable swingline lender may agree. The adjusted term SOFR and adjusted daily simple SOFR include a fixed credit adjustment of 0.10% over the applicable SOFR reference rate. Loans denominated in foreign currencies bear interest at a rate per annum equal to the applicable benchmark rate set forth in the Amended Credit Agreement plus an additional margin ranging from 1.00% to 1.75%, depending upon the Company's leverage ratio plus, if applicable, certain mandatory costs.

During the quarter ended September 30, 2025, all of the Company's borrowings under the Amended Credit Agreement were U.S. dollar loans. The spread in effect as of September 30, 2025 was 1.00%, plus a 0.10% credit spread adjustment for SOFR-based loans and 0.00% for alternate base rate loans. The commitment fee rate in effect at September 30, 2025 was 0.15%. The effective interest rates for the term loan were 5.26% and 5.43% as of September 30, 2025 and June 30, 2025, respectively. The Amended Credit Agreement includes customary representations, warranties and affirmative and negative covenants, including financial covenants. Specifically, the Company's Leverage Ratio must be less than or equal to 3.50 to 1.00 at all times. In addition, the Company's Interest Coverage Ratio (as such term is defined in the Amended Credit Agreement) must be at least 3.00 to 1.00 at the end of each fiscal quarter. In the event of a default, customary remedies are available to the lenders, including acceleration and increased interest rates. The Company was in compliance with all covenants under the Amended Credit Agreement at September 30, 2025.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

The average daily outstanding balance on the revolving credit facility, excluding the term loan facility, during the three month periods ended September 30, 2025 and 2024 was $1.1 million and $0.1 million, respectively. There was $350.0 million available for additional borrowings as of both September 30, 2025 and June 30, 2025. The effective interest rates for the revolving line of credit were 5.28% and 5.46% as of September 30, 2025 and June 30, 2025, respectively. There were no letters of credit issued under the multi-currency revolving credit facility at September 30, 2025 or June 30, 2025.

*Mississippi Revenue Bond*

On August 1, 2007, the Company entered into an agreement with the State of Mississippi to provide financing for the acquisition and installation of certain equipment to be utilized at the Company's Southaven, Mississippi warehouse, through the issuance of an industrial development revenue bond. The bond matures on September 1, 2032. The bond accrues interest at the one-month term SOFR plus an adjustment of 0.10% plus a spread of 0.85%. The agreement also provides the bondholder with a put option, exercisable only within 180 days of each fifth anniversary of the agreement, requiring the Company to pay back the bonds at 100% of the principal amount outstanding. At September 30, 2025, the Company was in compliance with all covenants under this bond. The interest rates at September 30, 2025 and June 30, 2025 were 5.27% and 5.28%, respectively.

*Debt Issuance Costs*

At September 30, 2025, net debt issuance costs associated with the credit facility and bond totaled $0.8 million and are being amortized on a straight-line basis through the maturity date of each respective debt instrument.

**(8) Derivatives and Hedging Activities**

The Company's results of operations could be materially impacted by significant changes in foreign currency exchange rates and interest rates. In an effort to manage the exposure to these risks, the Company periodically enters into various derivative instruments. The Company's accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments in accordance with U.S. GAAP. The Company records all derivatives on the Condensed Consolidated Balance Sheet at fair value. Derivatives that are not designated as hedging instruments or the ineffective portions of cash flow hedges are adjusted to fair value through earnings in other income and expense.

*Foreign Currency Derivatives* – The Company conducts a portion of its business internationally in a variety of foreign currencies and is exposed to market risk for changes in foreign currency exchange rates. The Company attempts to hedge transaction exposures with natural offsets to the fullest extent possible and once these opportunities have been exhausted the Company uses currency options and forward contracts or other hedging instruments with third parties. These contracts will periodically hedge the exchange of various currencies, including the U.S. dollar, Brazilian real, euro, British pound and Canadian dollar.

The Company had contracts outstanding for purposes of managing cash flows with notional amounts of $22.6 million and $26.2 million for the exchange of foreign currencies at September 30, 2025 and June 30, 2025, respectively. To date, the Company has chosen not to designate these derivatives as hedging instruments, and accordingly, these instruments are adjusted to fair value through earnings in other income and expense. Summarized financial information related to these derivative contracts and changes in the underlying value of the foreign currency exposures included in the Condensed Consolidated Income Statements for the quarters ended September 30, 2025 and 2024 are as follows:

---

| | | |
|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| Net foreign exchange derivative contract losses | $**655** | $941 |
| Net foreign currency transactional and re-measurement gains | **(307)** | (607) |
| &nbsp;&nbsp;Net foreign currency exchange losses | $**348** | $334 |

---

Net foreign currency exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign currency exchange contract gains and losses and are included in other income and expense. Foreign exchange gains and losses are primarily generated as the result of fluctuations in the value of the U.S. dollar versus the Brazilian real and the Canadian dollar versus the U.S. dollar.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

*Interest Rates -* The Company's earnings are also affected by changes in interest rates due to the impact those changes have on interest expense from floating rate debt instruments. The Company manages its exposure to changes in interest rates by using interest rate swaps to hedge this exposure and to achieve a desired proportion of fixed versus floating rate debt.

On April 30, 2019, the Company entered into an interest rate swap agreement to lock into a fixed LIBOR interest rate, which was amended on September 28, 2022, to change the reference rate from LIBOR to SOFR. The swap agreement has a notional amount of $100.0 million, with a $50.0 million tranche that matured on April 30, 2024 and a $50.0 million tranche scheduled to mature April 30, 2026.

On March 31, 2023, the Company entered into an interest rate swap agreement to lock into a fixed SOFR interest rate with a notional amount of $25.0 million and a maturity date of March 31, 2028.

These interest rate swap agreements are designated as cash flow hedges to hedge the variable rate interest payments on the revolving credit facility. Interest rate differentials paid or received under the swap agreements are recognized as adjustments to interest expense. To the extent the swaps are effective in offsetting the variability of the hedged cash flows, changes in the fair value of the swaps are not included in current earnings but are reported as other comprehensive income (loss). There was no ineffective portion to be recorded as an adjustment to earnings for the quarters ended September 30, 2025 and 2024.

The components of the cash flow hedge included in the Condensed Consolidated Statement of Comprehensive Income for the quarters ended September 30, 2025 and 2024, are as follows:

---

| | | |
|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| Net interest income recognized as a result of interest rate swap | $**(322)** | $(508) |
| Unrealized gain (loss) in fair value of interest rate swap | **15** | (885) |
| Net decrease in accumulated other comprehensive income | **(307)** | (1393) |
| Income tax effect | **(77)** | (343) |
| Net decrease in accumulated other comprehensive income, net of tax | $**(230)** | $(1050) |

---

The Company used the following derivative instruments at September 30, 2025 and June 30, 2025, reflected in its Condensed Consolidated Balance Sheets, for the risk management purposes detailed above:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **September 30, 2025** | **September 30, 2025** | **June 30, 2025** | **June 30, 2025** |
| |<br>**Balance Sheet Location** | **Fair Value of<br>Derivatives<br>Designated <br>as Hedge Instruments** | **Fair Value of<br>Derivatives<br>Not Designated as Hedge Instruments** | **Fair Value of<br>Derivatives<br>Designated <br>as Hedge Instruments** | **Fair Value of<br>Derivatives<br>Not Designated as Hedge Instruments** |
| | | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Derivative assets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward foreign currency exchange contracts | Prepaid expenses and other current assets | $**—** | $**—** | $— | $15 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest rate swap agreement | Other non-current assets | $**373** | $**—** | $680 | $— |
| Derivative liabilities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forward foreign currency exchange contracts | Accrued expenses and other current liabilities | $**—** | $**6** | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency hedge | Accrued expenses and other current liabilities | $**89** | $**—** | $290 | $— |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

 **(9) Fair Value of Financial Instruments**

Accounting guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Under this guidance, the Company classifies certain assets and liabilities based on the fair value hierarchy, which aggregates fair value measured assets and liabilities based upon the following levels of inputs:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Quoted prices in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e., supported by little or no market activity).

The assets and liabilities maintained by the Company that are required to be measured at fair value on a recurring basis include deferred compensation plan investments, forward foreign currency exchange contracts, foreign currency hedge agreements, interest rate swap agreements and contingent consideration owed to the sellers of Advantix Solutions Group, Inc ("Advantix") and Secure Path Networks, LLC dba Resourcive ("Resourcive"). The carrying value of debt is considered to approximate fair value, as the Company's debt instruments are indexed to a variable rate using the market approach (Level 2).

The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis at September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total** | **Quoted<br>prices in<br>active<br>markets<br>(Level 1)** | **Significant<br>other<br>observable<br>inputs<br>(Level 2)** | **Significant<br>unobservable<br>inputs<br>(Level 3)** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| **Assets:** | | | | |
| Deferred compensation plan investments, current and non-current | $**35388** | $**35388** | $**—** | $**—** |
| Interest rate swap agreement | **373** | **—** | **373** | **—** |
| &nbsp;&nbsp;Total assets at fair value | $**35761** | $**35388** | $**373** | $**—** |
| **Liabilities:** |  |  |  |  |
| Deferred compensation plan investments, current and non-current | $**35388** | $**35388** | $**—** | $**—** |
| Forward foreign currency exchange contracts | **6** | **—** | **6** | **—** |
| Foreign currency hedge | **89** | **—** | **89** | **—** |
| Liability for contingent consideration, current and non-current | **18039** | **—** | **—** | **18039** |
| &nbsp;&nbsp;Total liabilities at fair value | $**53522** | $**35388** | $**95** | $**18039** |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

The following table summarizes the valuation of the Company's remaining assets and liabilities measured at fair value on a recurring basis at June 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total** | **Quoted<br>prices in<br>active<br>markets<br>(Level 1)** | **Significant<br>other<br>observable<br>inputs<br>(Level 2)** | **Significant<br>unobservable<br>inputs<br>(Level 3)** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| **Assets:** | | | | |
| Deferred compensation plan investments, current and non-current | $31887 | $31887 | $— | $— |
| Forward foreign currency exchange contracts | 15 |  | 15 |  |
| Interest rate swap agreement | 680 |  | 680 |  |
| &nbsp;&nbsp;Total assets at fair value | $32582 | $31887 | $695 | $— |
| **Liabilities:** |  |  |  |  |
| Deferred compensation plan investments, current and non-current | $31887 | $31887 | $— | $— |
| Foreign currency hedge | 290 |  | 290 |  |
| Liability for contingent consideration, current and non-current | 19100 |  |  | 19100 |
| &nbsp;&nbsp;Total liabilities at fair value | $51277 | $31887 | $290 | $19100 |

---

The investments in the deferred compensation plan are held in a "rabbi trust" and include securities and cash equivalents for payment of non-qualified benefits for certain retired, terminated and active employees. These investments are recorded to prepaid expenses and other current assets or other non-current assets depending on their corresponding, anticipated distribution dates to recipients, which are reported in accrued expenses and other current liabilities or other long-term liabilities, respectively.

Derivative instruments, such as foreign currency forward contracts, are measured using the market approach on a recurring basis considering foreign currency spot rates and forward rates quoted by banks or foreign currency dealers and interest rates quoted by banks (Level 2). Fair values of interest rate swaps are measured using standard valuation models with inputs that can be derived from observable market transactions, including SOFR spot and forward rates (Level 2). Foreign currency contracts and interest rate swap agreements are classified in the Condensed Consolidated Balance Sheets as prepaid expenses and other non-current assets or accrued expenses and other long-term liabilities, depending on the respective instruments' favorable or unfavorable positions. See Note 8 - *Derivatives and Hedging Activities*.

The Company recorded a contingent consideration liability at the acquisition date of both Advantix and Resourcive. These liabilities represent the amounts payable to sellers, as outlined under the terms of the asset purchase agreements, based upon the achievement of a projected earnings before interest expense, taxes, depreciation and amortization, net of specific pro forma adjustments.

The following tables summarizes the fair value of the Company's contingent consideration liabilities at September 30, 2025 and September 30, 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Contingent consideration for the quarter ended** | **Contingent consideration for the quarter ended** | **Contingent consideration for the quarter ended** |
| | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Fair value at beginning of period | $**6660** | $**12440** | $**19100** |
| Payments | **(1375)** | **—** | **(1375)** |
| Change in fair value of contingent consideration | **145** | **169** | **314** |
| Fair value at end of period | $**5430** | $**12609** | $**18039** |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | | | |
|:---|:---|:---|:---|
| | **Contingent consideration for the quarter ended** | **Contingent consideration for the quarter ended** | **Contingent consideration for the quarter ended** |
| | **September 30, 2024** | **September 30, 2024** | **September 30, 2024** |
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Total** |
| | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| Fair value at beginning of period | $— | $— | $— |
| Issuance of contingent consideration | 7500 | 9700 | 17200 |
| Fair value at end of period | $7500 | $9700 | $17200 |

---

The fair values of amounts owed are recorded in current portion of contingent consideration and long-term portion of contingent consideration in the Company's Condensed Consolidated Balance Sheets. In accordance with ASC 805, the Company will revalue the contingent consideration liability at each reporting date through the last payment, with changes in the fair value of the contingent consideration reflected in the change in fair value of contingent consideration line item on the Company's Condensed Consolidated Income Statements that is included in the calculation of operating income. The fair value of the contingent consideration liability associated with future earnout payments is based on several factors, including but not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• estimated future results, net of pro forma adjustments set forth in the purchase agreements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a risk premium reflective of the Company's creditworthiness and market risk premium associated with the United States markets.

*Advantix*

Advantix is part of the Specialty Technology Solutions segment. The fair value of the contingent consideration is determined using a static discounted cash flow model. The fair value of the liability for the contingent consideration related to Advantix recognized at September 30, 2025 was $5.4 million, of which $1.8 million is classified as current. The change in fair value for the quarter ended September 30, 2025 is primarily due to the recurring amortization of the unrecognized fair value discount. The first earnout payment totaling $1.4 million was paid to the sellers of Advantix during the quarter ended September 30, 2025. Future earnout payments to the sellers of Advantix are payable based on results through fiscal year 2028.

*Resourcive*

Resourcive is part of the Intelisys & Advisory segment. The fair value of the contingent consideration for Resourcive is determined using a Monte Carlo simulation. The fair value of the liability for the contingent consideration related to Resourcive recognized at September 30, 2025 was $12.6 million, all of which is classified as non-current and is due to the sellers of Resourcive during fiscal year 2027. The change in fair value for the quarter ended September 30, 2025 is primarily due to the recurring amortization of the unrecognized fair value discount.

Valuation techniques and significant observable inputs used in recurring Level 3 fair value measurements for the Company's contingent consideration liabilities related to Advantix and Resourcive at September 30, 2025 were as follows.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Acquisition** | **Reporting Period** | **Valuation Technique** | **Significant Unobservable Inputs** | **Weighted Average Rates** |
| Advantix | September 30, 2025 | Discounted cash flow | Adjusted EBITDA risk premium | **15.3%** |
|  |  |  | Adjusted EBITDA growth rate | **22.0%** |
| Resourcive | September 30, 2025 | Monte Carlo | Adjusted EBITDA risk premium | **12.7%** |
|  |  |  | Simulated commission growth percentage | **24.2%** |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**(10) Segment Information**

The Company is a leading provider of technology solutions and services to channel sales partners in specialty technology markets. The Company's Chief Executive Officer is our Chief Operating Decision Maker ("CODM") who evaluates how we allocate resources, assess performance and make strategic and operational decisions. The CODM reviews key financial measures for each reportable segment based on various financial results including net sales, gross profit and operating income. These measures are assessed in the annual budget process as well as on an actual-to-budget comparison and an actual-to-forecast comparison when making decisions about the allocation of resources to each segment. In addition to financial results such as net sales, gross profit, and operating income, the CODM also considers a range of operational and financial metrics, including EBITDA, return on invested capital, customer metrics and other strategic indicators. These tools support a comprehensive view of performance and inform strategic decisions across our reportable segments.

Corporate primarily includes corporate service costs that are not included in the CODM's assessment of the performance of each of the identified reportable segments. In connection with that assessment, our CODM may exclude matters, such as charges for impairments, significant, higher-cost restructuring programs, costs associated with separation activities, acquisition costs and other related charges, certain gains and losses from acquisitions or dispositions and certain litigation settlements. The CODM also reviews certain other measures including total assets and property and equipment by segment and geography.

Based on such evaluations, the Company has two reportable segments based on sales model.

*Specialty Technology Solutions Segment*

The Specialty Technology Solutions segment operates primarily in the United States and Brazil and includes specialty technology solutions distributed through a wholesale/resale sales model. This segment includes hardware, SaaS and subscription services. The specialty technology solutions include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Mobility and barcode - mobile computing, barcode scanners and imagers, RFID (radio frequency identification devices), barcode printing and related services;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;POS - Point of Sale systems, integrated POS software platforms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Payment terminals - Self-service kiosks including self-checkout, payment terminals and mobile payment devices;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Physical security - video surveillance and analytics, video management software and access control;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• &nbsp;&nbsp;&nbsp;&nbsp;Networking - switching, routing and wireless products and software;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• &nbsp;&nbsp;&nbsp;&nbsp;Communications - voice, video, communication platform integration and contact center solutions; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• &nbsp;&nbsp;&nbsp;&nbsp;Connectivity - managed connectivity and wireless enablement solutions.

*Intelisys & Advisory Segment*

The Intelisys & Advisory segment operates in the United States and consists of sales and services to both channel sales partners (Intelisys) and end users (Advisory). As a technology services distributor, or TSD, Intelisys distributes connectivity, cloud and next-generation technologies through an agency sales model. Channel sales partners also have access to SaaS and subscription-based services through the company's proprietary tools, platforms and flexible routes to market. In addition to traditional telecom services, key technology areas include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Connectivity & SDN (Software-Defined Networking)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;CX (Unified Communications as a Service and Contact Center as a Service)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Cloud/Data Center

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Security

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Managed AI

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;Wireless & IoT

By offering flexible routes to market and a robust solutions portfolio, this segment helps advisors service a wide range of end users including businesses of all sizes from VSB ("Very Small Business") to Enterprise size businesses.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

Selected financial information about the Company's segments for the quarters ended September 30, 2025 and 2024 are presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Specialty Technology Solutions** | **Intelisys & Advisory** | **Corporate**<sup>(a)</sup> | **Total** |
| **Quarter ended September 30, 2025:** | | | | |
| Net Sales | $715447 | $24203 | $— | $739650 |
| Cost of sales | 631544 | 633 |  | 632177 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 83903 | 23570 |  | 107473 |
| Other operating expenses<sup>(b)</sup> | 63528 | 17752 | 290 | 81570 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | $20375 | $5818 | $(290) | $25903 |
| **Other Segment Items** |  |  |  |  |
| Depreciation and amortization<sup>(c)</sup> | $3970 | $2230 | $— | $6200 |
| Change in fair value of contingent consideration<sup>(d)</sup> | $145 | $169 | $— | $314 |
| Capital expenditures | $(2174) | $(221) | $— | $(2395) |
| **Quarter ended September 30, 2024:** |  |  |  |  |
| Net Sales | $752299 | $23281 | $— | $775580 |
| Cost of sales | 673842 | 119 |  | 673961 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 78457 | 23162 |  | 101619 |
| Other operating expenses<sup>(b)</sup> | 61719 | 16749 | 5521 | 83989 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | $16738 | $6413 | $(5521) | $17630 |
| **Other Segment Items** |  |  |  |  |
| Depreciation and amortization<sup>(c)</sup> | $4626 | $2125 | $720 | $7471 |
| Capital expenditures | $(2228) | $(147) | $— | $(2375) |
| <sup>(a)</sup> For the quarter ended September 30, 2025, the amount in Other operating expenses unallocated to the segments include restructuring expense, acquisition and divestiture, cyberattack restoration costs, as well as legal settlement. For the quarter ended September 30, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition and divestiture costs, as well as cyberattack restoration costs. | <sup>(a)</sup> For the quarter ended September 30, 2025, the amount in Other operating expenses unallocated to the segments include restructuring expense, acquisition and divestiture, cyberattack restoration costs, as well as legal settlement. For the quarter ended September 30, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition and divestiture costs, as well as cyberattack restoration costs. | <sup>(a)</sup> For the quarter ended September 30, 2025, the amount in Other operating expenses unallocated to the segments include restructuring expense, acquisition and divestiture, cyberattack restoration costs, as well as legal settlement. For the quarter ended September 30, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition and divestiture costs, as well as cyberattack restoration costs. | <sup>(a)</sup> For the quarter ended September 30, 2025, the amount in Other operating expenses unallocated to the segments include restructuring expense, acquisition and divestiture, cyberattack restoration costs, as well as legal settlement. For the quarter ended September 30, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition and divestiture costs, as well as cyberattack restoration costs. | <sup>(a)</sup> For the quarter ended September 30, 2025, the amount in Other operating expenses unallocated to the segments include restructuring expense, acquisition and divestiture, cyberattack restoration costs, as well as legal settlement. For the quarter ended September 30, 2024, the amount in Other operating expenses unallocated to the segments includes acquisition and divestiture costs, as well as cyberattack restoration costs. |
| <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses | <sup>(b)</sup> Primarily includes payroll and other employee expenses and other selling and general administrative expenses |
| <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  | <sup>(c)</sup> Depreciation and amortization expense is primarily included within Other operating expenses  |
| <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses | <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses | <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses | <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses | <sup>(d)</sup>Change in fair value of contingent consideration is included within Other operating expenses |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Quarter ended** | **Quarter ended** | **Quarter ended** | **Quarter ended** |
| | **September 30,** | **September 30,** | **September 30,** | **September 30,** |
| | **2025** | **2025** | **2024** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |
| **Sales by Geography Category:** |  |  |  |  |
| &nbsp;&nbsp;United States | **$** | **683094** | $| 715989 |
| &nbsp;&nbsp;Brazil | **57433** | **57433** | 63561 | 63561 |
| &nbsp;&nbsp;Less intercompany sales | **(877)** | **(877)** | (3970) | (3970) |
| Net sales <sup>(a)</sup> | **$** | **739650** | $| 775580 |
| <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended September 30, 2025 and 2024. |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **June 30, 2025** |
| | ***(in thousands)*** | ***(in thousands)*** |
| **Assets:** | | |
| &nbsp;&nbsp;Specialty Technology Solutions | $**1494057** | $1564119 |
| &nbsp;&nbsp;Intelisys & Advisory | **222919** | 221487 |
|  | $**1716976** | $1785606 |
| **Property and equipment, net by Geography Category:** |  |  |
| &nbsp;&nbsp;United States | $**14685** | $15047 |
| &nbsp;&nbsp;Brazil | **17536** | 16122 |
|  | $**32221** | $31169 |

---

**(11) Leases** 

In accordance with Accounting Standards Codification ("ASC") 842, at contract inception the Company determines if a contract contains a lease by assessing whether the contract contains an identified asset and whether the Company has the ability to control the asset. The Company also determines if the lease meets the classification criteria for an operating lease versus a finance lease under ASC 842. Substantially all of the Company's leases are operating leases for real estate, warehouse and office equipment ranging in duration from 1 year to 10 years. The Company has elected not to record short-term operating leases with an initial term of 12 months or less on the Condensed Consolidated Balance Sheets. Operating leases are recorded as other non-current assets, accrued expenses and other current liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. The Company has finance leases for information technology equipment expiring through fiscal year 2028. Finance leases are recorded as property and equipment, net, accrued expenses and other current liabilities and other long-term liabilities on the Condensed Consolidated Balance Sheets. The gross amount of the balances recorded related to finance leases is immaterial to the condensed consolidated financial statements at September 30, 2025 and the consolidated financial statements at June 30, 2025.

Operating lease right-of-use assets and lease liabilities are recognized at the commencement date based on the net present value of future minimum lease payments over the lease term. The Company generally is not able to determine the rate implicit in its leases and has elected to apply an incremental borrowing rate as the discount rate for the present value determination, which is based on the Company's cost of borrowings for the relevant terms of each lease and geographical economic factors. Certain operating lease agreements contain options to extend or terminate the lease. The lease term used is adjusted for these options when the Company is reasonably certain it will exercise the option. Operating lease expense is recognized on a straight-line basis over the lease term. Variable lease payments not based on a rate or index, such as costs for common area maintenance, are expensed as incurred. Further, the Company has elected the practical expedient under ASC 842 to recognize all lease and non-lease components as a single lease component, where applicable.

The following table presents amounts recorded on the Condensed Consolidated Balance Sheets related to operating leases at September 30, 2025 and June 30, 2025:

---

| | | | |
|:---|:---|:---|:---|
| | | **September 30, 2025** | **June 30, 2025** |
| **Operating leases** | **Balance Sheet location** | ***(in thousands)*** | ***(in thousands)*** |
| Operating lease right-of-use assets | Other non-current assets | $**10433** | $10258 |
| Current operating lease liabilities | Accrued expenses and other current liabilities | $**4066** | $3985 |
| Long-term operating lease liabilities | Other long-term liabilities | $**7139** | $6972 |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

The following table presents amounts recorded in operating lease expense as part of selling general and administrative expenses on the Condensed Consolidated Income Statements during the quarters ended September 30, 2025 and 2024. Operating lease costs contain immaterial amounts of short-term lease costs for leases with an initial term of 12 months or less.

---

| | | |
|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| Operating lease cost | $**1230** | $1121 |
| Variable lease cost | **360** | 332 |
|  | $**1590** | $1453 |

---

Supplemental cash flow information related to the Company's operating leases for the three months ended September 30, 2025 and 2024 are presented in the table below:

---

| | | |
|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| Cash paid for amounts in the measurement of lease liabilities | $**1136** | $1132 |
| Right-of-use assets obtained in exchange for lease obligations | **1385** | 2461 |

---

The weighted-average remaining lease term and discount rate at September 30, 2025 are presented in the table below:

---

| | |
|:---|:---|
| | **September 30, 2025** |
| Weighted-average remaining lease term | 3.11 years |
| Weighted-average discount rate | 6.40% |

---

The following table presents the maturities of the Company's operating lease liabilities at September 30, 2025:

---

| | |
|:---|:---|
| | **Operating leases** |
| | ***(in thousands)*** |
| 2026 | $3613 |
| 2027 | 4580 |
| 2028 | 2392 |
| 2029 | 1570 |
| 2030 | 999 |
| Total future payments | 13154 |
| Less: amounts representing interest | 1949 |
| Present value of lease payments | $11205 |

---

**(12) Commitments and Contingencies**

The Company is, from time to time, party to lawsuits arising out of operations. Although there can be no assurance, based upon information known to the Company, the Company believes that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on the Company's financial condition, results of operations or cash flows.

During the Company's due diligence for the Network1 acquisition, several pre-acquisition contingencies were identified regarding various Brazilian federal and state tax exposures. The Company recorded indemnification receivables that are reported gross of the pre-acquisition contingency liabilities as the funds were escrowed as part of the acquisition. There were no deposits or releases from the escrow account during the quarter ended September 30, 2025. During the fiscal year ended June 30, 2025, there were no deposits into the escrow account; however $0.2 million was released from the escrow account. The amount available after the impact of foreign currency translation, as of September 30, 2025 and June 30, 2025, for future pre-acquisition contingency settlements or to be released to the sellers was $3.6 million and $3.4 million, respectively.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

The Company has recorded pre-acquisition contingencies and corresponding indemnification receivables related to Network1 of $3.8 million and $3.7 million at September 30, 2025 and June 30, 2025, respectively. These balances are presented as other non-current liabilities and other non-current assets in the Consolidated Balance Sheets. The amount of reasonably possible undiscounted pre-acquisition contingencies as of September 30, 2025 is estimated to range from $3.8 million to $15.3 million at this time, of which all exposures are indemnifiable under the share purchase agreement.

**(13) Income Taxes**

Income taxes for the quarters ended September 30, 2025 and 2024 have been included in the accompanying condensed consolidated financial statements using an estimated annual effective tax rate. In addition to applying the estimated annual effective tax rate to pre-tax income, the Company includes certain items treated as discrete events to arrive at an estimated overall tax provision. There were no material discrete items recorded during the quarter ended September 30, 2025. A discrete net tax benefit of $0.8 million related to stock compensation was recorded during the quarter ended September 30, 2024.

The Company's effective tax rate of 26.4% for the quarter ended September 30, 2025, differs from the current federal statutory rate of 21% primarily as a result of income derived from tax jurisdictions with varying income tax rates, nondeductible expenses and state income taxes. The Company's effective tax rate was 26.1% for the quarter ended September 30, 2024.

As of September 30, 2025, the Company is not permanently reinvested with respect to all earnings generated by foreign operations. The Company has determined that there is no material deferred tax liability for federal, state and withholding tax related to undistributed earnings. During the quarter ended September 30, 2025, foreign subsidiaries did not repatriate cash to the United States. There is no certainty to the timing of any future distributions of such earnings to the U.S. in whole or in part.

The Company had approximately $0.7 million of total gross unrecognized tax benefits at September 30, 2025 and June 30, 2025, respectively. Of this total at September 30, 2025, approximately $0.6 million represents the amount of unrecognized tax benefits that are permanent in nature and, if recognized, would affect the annual effective tax rate. The Company does not believe that the total amount of unrecognized tax benefits will significantly increase or decrease within twelve months of the reporting date.

The Company's policy is to recognize interest and penalties related to income tax matters in income tax expense. At September 30, 2025 and June 30, 2025, the Company had approximately $1.0 million accrued for interest and penalties.

The Company conducts business internationally and one or more of its subsidiaries files income tax returns in the U.S. federal, various state, local and foreign jurisdictions. In the normal course of business, the Company is subject to examination by taxing authorities in countries and states in which it operates. With certain exceptions, the Company is no longer subject to federal, state and local or non-U.S. income tax examinations by tax authorities for the years before June 30, 2020.

**(14) Restructurings**

In January 2024 and September 2024, as part of a strategic review of organizational structure and operations, the Company executed cost reduction and restructuring programs to align our cost structure with demand expectations in our business.

Accrued restructuring costs are included in accrued expenses and other current liabilities on the Condensed Consolidated Balance Sheets. The following table represents activity for the three months ended September 30, 2025:

---

| | |
|:---|:---|
| | **Accrued Expenses** |
| | ***(in thousands)*** |
| Balance at June 30, 2025 | $**555** |
| &nbsp;&nbsp;Cash payments | **(404)** |
| Balance at September 30, 2025 | $**151** |

---

The remaining balance as of September 30, 2025 of $0.2 million is expected to be paid through the third quarter of fiscal year 2026.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**(15) Business Acquisitions**

On August 8, 2024, ScanSource acquired substantially all of the assets of Resourcive, a leading technology advisor, through its subsidiary ScanSource Agency, Inc. Resourcive delivers strategic IT sourcing solutions to mid-market and enterprise businesses. On August 15, 2024, ScanSource acquired, through its subsidiary Advantix ScanSource, LLC, substantially all of the assets of Advantix, a managed connectivity experience provider specializing in wireless enablement solutions. The combined initial purchase price of these acquisitions, net of cash acquired, was approximately $56.7 million. The Advantix acquisition is included in the Specialty Technology Solutions segment, and the Resourcive acquisition is included in the Intelisys & Advisory segment. Both acquisitions included future earnout payments, and the Company recorded contingent consideration liabilities at the acquisition dates representing the fair value of estimated amounts payable to sellers. See Note 9 - *Fair Value of Financial Instruments* for the related disclosures regarding the contingent consideration liabilities recognized in connection with these acquisitions.

The purchase prices were allocated to the assets acquired and liabilities assumed based on their estimated fair values on the transaction dates. Intangible assets acquired include trade names, customer relationships, and developed technology. See Note 6 - *Goodwill and Other Identifiable Intangible Assets* for the amounts of goodwill and intangible assets recognized in connection with these acquisitions. The allocation of the purchase prices to the assets and liabilities acquired, including the valuation of the identifiable intangible assets, has not been concluded as of the reporting date. The impact of these acquisitions was not material to the consolidated financial statements.

The Company continues to evaluate acquisitions on an on-going basis and has recognized $0.3 million and $0.4 million in acquisition-related costs for the quarters ended September 30, 2025 and September 30, 2024, respectively. Acquisition-related costs are included in selling, general and administrative expenses on the Condensed Consolidated Income Statements.

**(16) Subsequent Events**

On October 20, 2025, ScanSource completed the acquisition of DataXoom, a leading connectivity provider dedicated to supporting purpose-built mobile deployments across our current supplier line card and beyond. DataXoom complements our Advantix investment and adds 17 employees through the acquisition. This acquisition will be included in the Specialty Technology Solutions segment in future periods.

---

| | |
|:---|:---|
| **Item 2.** | **Management's Discussion and Analysis of Financial Condition and Results of Operations** |

---

**Overview**

ScanSource is a leading technology distributor connecting devices to the cloud and accelerating growth for channel sales partners across hardware, SaaS, connectivity and cloud. We provide technology solutions and services from approximately 500 leading suppliers of mobility and barcode, POS, payment terminals, physical security, networking, communications, connectivity and cloud services to our approximately 25,000 channel sales partners located primarily in the United States and Brazil.

We operate our business under a management structure that enhances our technology distribution growth strategy. Our segments operate primarily in the United States and Brazil:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Specialty Technology Solutions

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Intelisys & Advisory

We sell hardware, SaaS, connectivity and cloud solutions and services to channel sales partners that are designed to solve end users' challenges. We operate distribution facilities that primarily support our United States business in Mississippi, California and Kentucky. Brazil distribution facilities are located in the Brazilian states of Paraná, Espirito Santo and Santa Catarina. We provide some of our digital products, which include SaaS and subscriptions, through our digital tools and platforms.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**Recent Developments**

*Impact of the Macroeconomic Environment, Including Growth Outlook, Inflation and Tariffs*

The macroeconomic environment, including the economic impacts of growth outlook, inflation, tariffs and shifting relations between the U.S. and other countries, continues to create significant uncertainty and may adversely affect our financial condition and results of operations. In 2025, the U.S. announced a variety of additional tariffs on goods from multiple nations and trading blocks and has been targeted with reciprocal tariffs and other retaliatory actions in response. Negotiations and the state of international trade policy and relations continue to evolve. We are mindful of the potential impact these conditions could have on our channel sales partners, suppliers and end-user demand and we are actively monitoring changes to the global macroeconomic environment and assessing the potential impacts these challenges may have on our financial condition, results of operations and liquidity. We expect to pass any price increases from our suppliers resulting from tariffs to our channel sales partners. We are also mitigating risks through strategic planning and maintaining financial flexibility, but we cannot predict the outcome of our mitigation strategies or the ultimate impact of tariffs and the global macroeconomic environment on our financial condition or results of operations.

On July 4, 2025, the One Big Beautiful Bill Act (the "Act") was signed into law. The Act permanently extends key provisions of the Tax Cuts and Jobs Act, including 100% bonus depreciation, and introduces changes to the international tax framework. We are currently assessing the impact of the Act on our future effective tax rate, tax liabilities, and cash taxes.

**Our Strategy**

Our strategy is to drive sustainable, profitable growth by providing complex, converging technology solutions through a growing ecosystem of channel sales partners leveraging our people, processes and tools. Our goal is to provide exceptional experiences for our channel sales partners, suppliers and employees, and we strive for operational excellence. Our differentiated technology distribution strategy utilizes multiple sales models to offer hardware, SaaS, connectivity and cloud services from leading technology suppliers to channel sales partners that solve end users' challenges. ScanSource enables channel sales partners to deliver solutions for their end users to address changing buying and consumption patterns. Our solutions may include a combination of offerings from multiple suppliers or give our channel sales partners access to additional services. As a trusted adviser to our channel sales partners, we provide converged solutions through our strong understanding of end-user needs.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**Results of Operations**

***Net Sales***

We have two reportable segments, which are based on sales channels. The following tables summarize our net sales results by operating segment and by geographic location for the quarters ended September 30, 2025 and 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** | | | **% Change, Constant Currency, Excluding Divestitures and Acquisitions** <sup>(a)</sup> |
| ***Net Sales by Segment:*** | **2025** | **2024** | **$ Change** | **% Change** | **% Change, Constant Currency, Excluding Divestitures and Acquisitions** <sup>(a)</sup> |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| Specialty Technology Solutions | $**715447** | $752299 | $(36852) | (4.9)% | (5.6)% |
| Intelisys & Advisory | **24203** | 23281 | 922 | 4.0% | 0.7% |
| &nbsp;&nbsp;&nbsp;Total net sales | $**739650** | $775580 | $(35930) | (4.6)% | (5.4)% |

---

<sup>(a)</sup> A reconciliation of non-GAAP net sales in constant currency, excluding divestitures and acquisitions, is presented at the end of *Results of Operations*, under *Non-GAAP Financial Information.*

***<u>Specialty Technology Solutions</u>***

The Specialty Technology Solutions segment consists of sales to channel partners primarily in the United States and Brazil. For the quarter ended September 30, 2025, net sales decreased $36.9 million, or 4.9%, compared to the prior-year period. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales decreased $41.6 million, or 5.6%, compared to the prior-year period. For the quarter ended September 30, 2025, net sales decreased primarily due to lower large deals.

***<u>Intelisys & Advisory</u>***

The Intelisys & Advisory segment consists of sales and services to both channel partners (Intelisys) and end users (Advisory) in the United States. For the quarter ended September 30, 2025, net sales increased $0.9 million, or 4.0%, compared to the prior-year period. The increase in net sales reflects the addition of an acquisition. Excluding the impact from foreign exchange rate fluctuations and the impact of acquisitions, adjusted net sales increased $0.2 million, or 0.7% for the quarter ended September 30, 2025. The increase in net sales for the quarter ended September 30, 2025 reflects Intelisys net sales growth. Quarterly net billings for Intelisys increased 1.7% over the prior-year quarter to bring annualized net billings to approximately $2.78 billion.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** | | | **% Change, Constant Currency, Excluding Divestitures and Acquisitions** <sup>(a)</sup> |
| ***Net Sales by Geography:*** | **2025** | **2024** | **$ Change** | **% Change** | **% Change, Constant Currency, Excluding Divestitures and Acquisitions** <sup>(a)</sup> |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| United States | $**682217** | $712019 | $(29802) | (4.2)% | (4.8)% |
| Brazil | **57433** | 63561 | (6128) | (9.6)% | (11.4)% |
| &nbsp;&nbsp;Total net sales <sup>(b)</sup> | $**739650** | $775580 | $(35930) | (4.6)% | (5.4)% |

---

<sup>(a)</sup> A reconciliation of non-GAAP net sales in constant currency is presented at the end of *Results of Operations* in the non-GAAP section.

<sup>(b)</sup> Countries outside of the United States and Brazil represent less than 5.0% of net sales for the quarters ended September 30, 2025 and 2024.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

***Gross Profit***

The following table summarizes our gross profit for the quarters ended September 30, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** | | | **% of Net Sales September 30,** | **% of Net Sales September 30,** |
| | **2025** | **2024** |<br>**$ Change** |<br>**% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Specialty Technology Solutions | $**83903** | $78457 | $5446 | 6.9% | **11.7%** | 10.4% |
| Intelisys & Advisory | **23570** | 23162 | 408 | 1.8% | **97.4%** | 99.5% |
| &nbsp;&nbsp;&nbsp;Gross profit | $**107473** | $101619 | $5854 | 5.8% | **14.5%** | 13.1% |

---

Our gross profit is primarily affected by sales volume and gross margin mix. Gross margin mix is impacted by multiple factors, which include sales mix (proportion of sales of higher margin products or services relative to total sales), supplier program recognition (consisting of volume rebates, inventory price changes and purchase discounts) and freight costs. Increases in supplier program recognition decrease cost of goods sold, thereby increasing gross profit. Net sales derived from our Intelisys business contribute 100% to our gross profit dollars and margin as they have no associated cost of goods sold.

***<u>Specialty Technology Solutions</u>***

For the quarter ended September 30, 2025, gross profit dollars for the Specialty Technology Solutions segment increased $5.4 million, or 6.9%, compared to the prior-year quarter. Favorable supplier program recognition and sales mix positively impacted gross profit by $9.2 million. Lower sales volume, after considering cost of goods sold, reduced gross profit by $3.8 million for the quarter. Gross profit margin increased 130 basis points over the prior-year quarter to 11.7%.

***<u>Intelisys & Advisory</u>***

For the quarter ended September 30, 2025, gross profit dollars for the Intelisys & Advisory segment increased $0.4 million, or 1.8%, compared to the prior-year quarter. Higher sales volume, largely due to the impact of our Resourcive acquisition, increased gross profit for the quarter. Gross profit margin decreased 211 basis points compared to the prior-year quarter to 97.4%, reflecting the addition of professional services to the sales mix.

***Operating Expenses***

The following table summarizes our operating expenses for the quarters ended September 30, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** | | | **% of Net Sales September 30,** | **% of Net Sales September 30,** |
| | **2025** | **2024** |<br>**$ Change** |<br>**% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Selling, general and administrative expenses | $**75275** | $71706 | $3569 | 5.0% | **10.2%** | 9.2% |
| Depreciation expense | **1577** | 2857 | (1280) | (44.8)% | **0.2%** | 0.4% |
| Intangible amortization expense | **4404** | 4358 | 46 | 1.1% | **0.6%** | 0.6% |
| Restructuring and other charges | **—** | 5068 | (5068) | (100.0)% | **0.0%** | 0.7% |
| Change in fair value of contingent consideration | **314** |  | 314 | *\*nm* | **0.0%** | 0.0% |
| &nbsp;&nbsp;Operating expenses | $**81570** | $83989 | $(2419) | (2.9)% | **11.0%** | 10.8% |

---

Selling, general and administrative expenses ("SG&A") increased by $3.6 million, or 5.0%, for the quarter ended September 30, 2025, compared to the prior-year period. The increase for the quarter is primarily attributable to increased costs for employee-related expenses and costs related to acquisitions.

The decrease in depreciation expense of $1.3 million during the quarter ended September 30, 2025, is largely due to certain ERP software assets being fully depreciated in the previous fiscal year.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

Restructuring and other charges of $5.1 million were incurred in the quarter ended September 30, 2024. Restructuring and other charges relate to employee separation and benefit costs in connection with our expense reduction and restructuring plans implemented during the current and prior fiscal year.

We present changes in fair value of the contingent consideration owed to the former shareholders of businesses that we acquire as a separate line item in operating expenses. We recorded a fair value adjustment expense of $0.3 million in the quarter ended September 30, 2025. The expense from changes in fair value of contingent consideration for the quarter is largely due to the recurring amortization of the unrecognized fair value discount.

***Operating Income***

The following table summarizes our operating income for the quarters ended September 30, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** | | | **% of Net Sales September 30,** | **% of Net Sales September 30,** |
| | **2025** | **2024** |<br>**$ Change** |<br>**% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Specialty Technology Solutions | $**20375** | $16738 | $3637 | 21.7% | **2.8%** | 2.2% |
| Intelisys & Advisory | **5818** | 6413 | (595) | (9.3)% | **24.0%** | 27.5% |
| Corporate | **(290)** | (5521) | 5231 | nm\* | **nm\*** | nm\* |
| &nbsp;&nbsp;Operating income | $**25903** | $17630 | $8273 | 46.9% | **3.5%** | 2.3% |

---

*\*nm - percentages are not meaningful*

***<u>Specialty Technology Solutions</u>***

For the Specialty Technology Solutions segment, operating income increased $3.6 million, or 21.7%, for the quarter ended September 30, 2025, compared to the prior-year periods. Operating margin was 2.8% and 2.2% for the quarters ended September 30, 2025 and September 30, 2024, respectively. The increase in operating income for the quarter is primarily due to higher gross profits for the quarter.

***<u>Intelisys & Advisory</u>***

For the Intelisys & Advisory segment, operating income decreased $0.6 million, or 9.3%, for the quarter ended September 30, 2025. Operating margin decreased to 24.0% for the quarter ended September 30, 2025. The decrease in operating income for the quarter ended September 30, 2025 is primarily driven by higher employee-related expenses during the quarter.

***<u>Corporate</u>***

For the quarter ended September 30, 2025, Corporate operating losses of $0.3 million represents acquisition-related costs.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

***Total Other (Income) Expense***

The following table summarizes our total other (income) expense for the quarters ended September 30, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** | | | **% of Net Sales September 30,** | **% of Net Sales September 30,** |
| | **2025** | **2024** |<br>**$ Change** |<br>**% Change** | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| Interest expense | $**1914** | $2109 | $(195) | (9.2)% | **0.3%** | 0.3% |
| Interest income | **(3180)** | (2659) | (521) | 19.6% | **(0.4)%** | (0.3)% |
| Net foreign exchange losses | **348** | 334 | 14 | 4.2% | **0.0%** | 0.0% |
| Other, net | **(175)** | (5116) | 4941 | (96.6)% | **(0.0)%** | (0.7)% |
| &nbsp;&nbsp;Total other (income) expense, net | $**(1093)** | $(5332) | $4239 | (79.5)% | **(0.1)%** | (0.7)% |

---

*\*nm - percentages are not meaningful*

Interest expense consists primarily of interest incurred on borrowings, non-utilization fees charged on the revolving credit facility and amortization of debt issuance costs. Interest expense decreased for the quarter ended September 30, 2025 compared to the prior-year period, primarily from lower average borrowings on our multi-currency revolving credit facility and lower interest rates.

Interest income increased for the quarter ended September 30, 2025 primarily from higher interest income in Brazil.

Net foreign exchange gains and losses consist of foreign currency transactional and functional currency re-measurements, offset by net foreign exchange forward contracts gains and losses. Foreign exchange gains and losses are generated as the result of fluctuations in the value of the U.S. dollar versus the Brazilian real, the Canadian dollar versus the U.S. dollar, the euro versus the U.S. dollar, and the British pound versus the U.S. dollar. We partially offset foreign currency exposure with the use of foreign exchange contracts to hedge against these exposures. The costs associated with foreign exchange forward contracts are included in the net foreign exchange losses.

Other net income decreased for the quarter ended September 30, 2025, as we recognized a $5.1 million gain in the prior-year period related to an insurance recovery in connection with the cybersecurity attack in fiscal year 2023.

***Provision for Income Taxes***

For the quarter ended September 30, 2025, income tax expense was $7.1 million reflecting an effective tax rate of 26.4%. In comparison, for the quarter ended September 30, 2024, income tax expense was $6.0 million reflecting an effective tax rate of 26.1%. We expect the effective tax rate, excluding discrete items, for fiscal year 2026 to be approximately 27.2% to 28.2%. See Note 13 - Income Taxes to the Notes to Consolidated Financial Statements for further discussion.

**Non-GAAP Financial Information**

*Evaluating Financial Condition and Operating Performance*

In addition to disclosing results that are determined in accordance with United States generally accepted accounting principles ("US GAAP" or "GAAP"), we also disclose certain non-GAAP financial measures. These measures include non-GAAP operating income; non-GAAP pre-tax income; non-GAAP net income; non-GAAP EPS; adjusted earnings before interest expense, income taxes, depreciation, and amortization ("adjusted EBITDA"); adjusted return on invested capital ("adjusted ROIC"); and constant currency. Constant currency is a measure that excludes the translation exchange impact from changes in foreign currency exchange rates between reporting periods. We use non-GAAP financial measures to better understand and evaluate performance, including comparisons from period to period.

These non-GAAP financial measures have limitations as analytical tools, and the non-GAAP financial measures that we report may not be comparable to similarly titled amounts reported by other companies. Analysis of results and outlook on a non-GAAP basis should be considered in addition to, and not in substitution for or as superior to, measurements of financial performance prepared in accordance with US GAAP.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

*Adjusted Return on Invested Capital*

Adjusted ROIC assists us in comparing our performance over various reporting periods on a consistent basis because it removes from our operating results the impact of items that do not reflect our core operating performance. We believe the calculation of adjusted ROIC provides useful information to investors and is an additional relevant comparison of our performance during the year.

Adjusted EBITDA starts with net income and adds back interest expense, income tax expense, depreciation expense, amortization of intangible assets, share-based compensation expense, and other non-GAAP adjustments. Since adjusted EBITDA excludes some non-cash costs of investing in our business and people, we believe that adjusted EBITDA shows the profitability from our business operations more clearly.

We calculate adjusted ROIC as adjusted EBITDA, divided by invested capital. Invested capital is defined as average equity plus average daily funded interest-bearing debt for the period. The following table summarizes annualized adjusted ROIC for the quarters ended September 30, 2025 and 2024, respectively:

---

| | | |
|:---|:---|:---|
|  | **Quarter ended September 30,** | **Quarter ended September 30,** |
| | **2025** | **2024** |
| Adjusted return on invested capital ratio, annualized <sup>(a)</sup> | **14.6%** | 13.3% |

---

(a)The annualized EBITDA amount is divided by days in the quarter times 365 days per year, or 366 days for leap year. There were 92 days in the current and in the prior-year quarter.

The components of this calculation and reconciliation to our financial statements are shown on the following schedule:

---

| | | |
|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| ***Reconciliation of net income to adjusted EBITDA:*** |  |  |
| &nbsp;&nbsp;Net income (GAAP) | $**19878** | $16974 |
| &nbsp;&nbsp;Plus: Interest expense | **1914** | 2109 |
| &nbsp;&nbsp;Plus: Income taxes | **7118** | 5988 |
| &nbsp;&nbsp;Plus: Depreciation and amortization | **6200** | 7471 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA (non-GAAP) | **35110** | 32542 |
| &nbsp;&nbsp;Plus: Change in fair value of contingent consideration | **314** |  |
| &nbsp;&nbsp;Plus: Share-based compensation | **2876** | 2471 |
| &nbsp;&nbsp;Plus: Acquisition and divestiture costs <sup>(a)</sup> | **261** | 377 |
| &nbsp;&nbsp;Plus: Cyberattack restoration costs | **29** | 76 |
| &nbsp;&nbsp;Plus: Restructuring costs | **—** | 5068 |
| &nbsp;&nbsp;Plus: Insurance recovery, net of payments | **—** | (4868) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA (numerator for adjusted ROIC) (non-GAAP) | $**38590** | $35666 |

---

(a) Acquisition and divestiture costs are generally non-deductible for tax purposes.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | | |
|:---|:---|:---|
| | **Quarter ended September 30,** | **Quarter ended September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| ***Invested capital calculations:*** |  |  |
| &nbsp;&nbsp;Equity – beginning of the quarter | $**906409** | $924254 |
| &nbsp;&nbsp;Equity – end of the quarter | **914032** | 920893 |
| &nbsp;&nbsp;Plus: Change in fair value of contingent consideration, net of tax | **236** |  |
| &nbsp;&nbsp;Plus: Share-based compensation, net | **2152** | 1856 |
| &nbsp;&nbsp;Plus: Acquisition and divestiture costs <sup>(a)</sup> | **261** | 377 |
| &nbsp;&nbsp;Plus: Cyberattack restoration costs, net | **21** | 57 |
| &nbsp;&nbsp;Plus: Restructuring, net | **—** | 3818 |
| &nbsp;&nbsp;Plus: Insurance recovery, net of payments | **—** | (3667) |
| &nbsp;&nbsp;Average equity | **911556** | 923794 |
| &nbsp;&nbsp;Average funded debt <sup>(b)</sup> | **137113** | 144020 |
| &nbsp;&nbsp;&nbsp;&nbsp;Invested capital (denominator for adjusted ROIC) (non-GAAP) | $**1048669** | $1067814 |

---

(a) Acquisition and divestiture costs are generally non-deductible for tax purposes.

(b)Average funded debt is calculated as the daily average amounts outstanding on our short-term and long-term interest-bearing debt.

*Net Sales in Constant Currency Excluding Acquisitions and Divestitures*

We make references to "constant currency," a non-GAAP performance measure that excludes the foreign exchange rate impact from fluctuations in the average foreign exchange rates between reporting periods. Constant currency is calculated by translating current period results from currencies other than the U.S. dollar into U.S. dollars using the comparable average foreign exchange rates from the prior-year period. We also exclude the impact of acquisitions or divestitures prior to the first full year of operations from the acquisition or divestiture date in order to show net sales results on an organic basis. This information is provided to analyze underlying trends without the translation impact of fluctuations in foreign currency rates and the impact of acquisitions and divestitures. Below we show organic growth by providing a non-GAAP reconciliation of net sales in constant currency excluding acquisitions and divestitures:

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| ***Net Sales by Segment:*** | | | | |
| | **Quarter ended September 30,** | **Quarter ended September 30,** | | |
|  | **2025** | **2024** | **$ Change** | **% Change** |
| **Specialty Technology Solutions:** | ***(in thousands)*** | ***(in thousands)*** |  |  |
| &nbsp;&nbsp;Net sales, reported | $**715447** | $752299 | $(36852) | (4.9)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(a)</sup> | **(1085)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(7171)** | (3512) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**707191** | $748787 | $(41596) | (5.6)% |
| **Intelisys & Advisory:** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported | $**24203** | $23281 | $922 | 4.0% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(a)</sup> | **(3)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(1336)** | (577) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**22864** | $22704 | $160 | 0.7% |
| **Consolidated:** |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported | $**739650** | $775580 | $(35930) | (4.6)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(a)</sup> | **(1088)** |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(8507)** | (4089) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | $**730055** | $771491 | $(41436) | (5.4)% |
| <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(a)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| ***Net Sales by Geography:*** | | | | | | | |
| | **Quarter ended September 30,** | **Quarter ended September 30,** | **Quarter ended September 30,** | **Quarter ended September 30,** | | | |
|  | **2025** | **2025** | **2024** | **2024** | **$ Change** | **$ Change** | **% Change** |
| **United States:** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |
| &nbsp;&nbsp;Net sales, reported <sup>(a)</sup> | **$** | **682217** | $| 712019 | $| (29802) | (4.2)% |
| &nbsp;&nbsp;Less: Acquisitions | **(8507)** | **(8507)** | (4089) | (4089) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales | **$** | **673710** | $| 707930 | $| (34220) | (4.8)% |
| **Brazil:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported <sup>(b)</sup> | **$** | **57433** | $| 63561 | $| (6128) | (9.6)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(c)</sup> | **(1088)** | **(1088)** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales, constant currency | **$** | **56345** | $| 63561 | $| (7216) | (11.4)% |
| **Consolidated:** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Net sales, reported  | **$** | **739650** | $| 775580 | $| (35930) | (4.6)% |
| &nbsp;&nbsp;Foreign exchange impact <sup>(c)</sup> | **(1088)** | **(1088)** |  |  |  |  |  |
| &nbsp;&nbsp;Less: Acquisitions | **(8507)** | **(8507)** | (4089) | (4089) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP net sales, constant currency | **$** | **730055** | $| 771491 | $| (41436) | (5.4)% |
| <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended September 30, 2025 and 2024. | <sup>(a)</sup> Includes net sales in Canada that are supported by U.S. operations and represent less than 5.0% of United States net sales for the quarters ended September 30, 2025 and 2024. |
| <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.2% of Brazil net sales for the quarters ended September 30, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.2% of Brazil net sales for the quarters ended September 30, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.2% of Brazil net sales for the quarters ended September 30, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.2% of Brazil net sales for the quarters ended September 30, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.2% of Brazil net sales for the quarters ended September 30, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.2% of Brazil net sales for the quarters ended September 30, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.2% of Brazil net sales for the quarters ended September 30, 2025 and 2024. | <sup>(b)</sup> Includes net sales from outside of the United States, Canada and Brazil, which represent less than 0.2% of Brazil net sales for the quarters ended September 30, 2025 and 2024. |
| <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. | <sup>(c)</sup> Year-over-year net sales growth rate excluding the translation impact of changes in foreign currency exchange rates. Calculated by translating the net sales for the quarter ended September 30, 2025 into U.S. dollars using the average foreign exchange rates for the quarter ended September 30, 2024. |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| ***Operating Income by Segment:*** | | | | | | |
| | **Quarter ended September 30,** | **Quarter ended September 30,** | | | **% of Net Sales September 30,** | **% of Net Sales September 30,** |
|  | **2025** | **2024** | **$ Change** | **% Change** | **2025** | **2024** |
| **Specialty Technology Solutions:** | ***(in thousands)*** | ***(in thousands)*** |  |  |  |  |
| GAAP operating income | $**20375** | $16738 | $3637 | 21.7% | **2.8%** | 2.2% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **2216** | 2276 | (60) |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **145** |  | 145 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**22736** | $19014 | $3722 | 19.6% | **3.2%** | 2.5% |
| **Intelisys & Advisory:** |  |  |  |  |  |  |
| GAAP operating income | $**5818** | $6413 | $(595) | (9.3)% | **24.0%** | 27.5% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **2188** | 2082 | 106 |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **169** |  | 169 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**8175** | $8495 | $(320) | (3.8)% | **33.8%** | 36.5% |
| **Corporate:** |  |  |  |  |  |  |
| GAAP operating loss | $**(290)** | $(5521) | $5231 | nm\* | **nm\*** | nm\* |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition and divestiture costs | **261** | 377 | (116) |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring costs | **—** | 5068 | (5068) |  |  |  |
| &nbsp;&nbsp;&nbsp;Cyberattack restoration costs | **29** | 76 | (47) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**—** | $— | $— | nm\* | **nm\*** | nm\* |
| **Consolidated:** |  |  |  |  |  |  |
| GAAP operating income | $**25903** | $17630 | $8273 | 46.9% | **3.5%** | 2.3% |
| Adjustments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | **4404** | 4358 | 46 |  |  |  |
| &nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | **314** |  | 314 |  |  |  |
| &nbsp;&nbsp;&nbsp;Acquisition and divestiture costs | **261** | 377 | (116) |  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring costs | **—** | 5068 | (5068) |  |  |  |
| &nbsp;&nbsp;&nbsp;Cyberattack restoration costs | **29** | 76 | (47) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-GAAP operating income | $**30911** | $27509 | $3402 | 12.4% | **4.2%** | 3.5% |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

*Additional Non-GAAP Metrics* 

To evaluate current period performance on a more consistent basis with prior periods, we disclose non-GAAP SG&A expenses, non-GAAP operating income, non-GAAP pre-tax income, non-GAAP net income and non-GAAP diluted earnings per share. Non-GAAP results exclude amortization of intangible assets related to divestitures, cyberattack restoration costs and other non-GAAP adjustments. These year-over-year metrics include the translation impact of changes in foreign currency exchange rates. These metrics are useful in assessing and understanding our operating performance, especially when comparing results with previous periods or forecasting performance for future periods. Below we provide a non-GAAP reconciliation of the aforementioned metrics adjusted for the costs and charges mentioned above:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** | **Quarter ended September 30, 2025** |
| | **GAAP <br>Measure** | **Intangible <br>amortization <br>expense** | **Change in fair value of contingent consideration** | **Acquisition and Divestiture costs** <sup>(a)</sup> | **Restructuring costs** | **Insurance recovery** | **Cyberattack <br>restoration costs** | **Non-GAAP <br>measure** |
| | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** |
| SG&A expenses | $**75275** | $**—** | $**—** | $**(261)** | $**—** | $**—** | $**(29)** | $**74985** |
| Operating income | **25903** | **4404** | **314** | **261** | **—** | **—** | **29** | **30911** |
| Pre-tax income | **26996** | **4404** | **314** | **261** | **—** | **—** | **29** | **32004** |
| Net income | **19878** | **3289** | **236** | **261** | **—** | **—** | **21** | **23685** |
| Diluted EPS | $**0.89** | $**0.15** | $**0.01** | $**0.01** | $**—** | $**—** | $**—** | $**1.06** |
|  | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** | **Quarter ended September 30, 2024** |
|  | **GAAP <br>Measure** | **Intangible <br>amortization <br>expense** | **Change in fair value of contingent consideration** | **Acquisition and Divestiture costs** <sup>(a)</sup> | **Restructuring costs** | **Insurance recovery** | **Cyberattack <br>restoration costs** | **Non-GAAP <br>measure** |
|  | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** | ***(in thousands, except per share data)*** |
| SG&A expenses | $71706 | $— | $— | $(377) | $— | $— | $(76) | $71253 |
| Operating income | 17630 | 4358 |  | 377 | 5068 |  | 76 | 27509 |
| Pre-tax income | 22962 | 4358 |  | 377 | 5068 | (4868) | 76 | 27973 |
| Net income | 16974 | 3264 |  | 377 | 3818 | (3667) | 57 | 20823 |
| Diluted EPS | $0.69 | $0.13 | $— | $0.02 | $0.15 | $(0.15) | $— | $0.84 |
| (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. | (a) Acquisition and divestiture costs for the quarters ended September 30, 2025 and 2024 are generally nondeductible for tax purposes. |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**Liquidity and Capital Resources**

Our primary sources of liquidity are cash flows from operations and borrowings under our $350 million revolving credit facility. Our business requires significant investment in working capital, particularly accounts receivable and inventory, partially financed through our accounts payable to vendors, cash generated from operations and revolving lines of credit. In general, as our sales volume increases, our net investment in working capital increases, which typically results in decreased cash flow from operating activities. Conversely, when sales volume decreases, our net investment in working capital typically decreases, which typically results in increased cash flow from operating activities.

Our cash and cash equivalents balance totaled $124.9 million at September 30, 2025, compared to $126.2 million at June 30, 2025, including $43.2 million and $46.3 million held outside of the United States at September 30, 2025 and June 30, 2025, respectively. Checks released but not yet cleared in the amount of $0.1 million are included in accounts payable at September 30, 2025 and June 30, 2025.

We conduct business primarily in the United States and Brazil where we generate and use cash. We provide for United States income taxes from the earnings of our Canadian and Brazilian subsidiaries. See Note 13 - *Income Taxes* in the Notes to the Consolidated Financial Statements for further discussion.

Our net investment in working capital, defined as accounts receivable plus inventories less accounts payable, increased $12.1 million to $532.8 million at September 30, 2025 from $520.7 million at June 30, 2025, primarily from decreases in accounts payable and increases in inventories, partially offset by lower accounts receivable as a result of lower sales volume. Our net investment in working capital is affected by several factors such as fluctuations in sales volume, net income, timing of collections from channel sales partners, increases and decreases to inventory levels and payments to vendors.

---

| | | |
|:---|:---|:---|
| | **Three months ended** | **Three months ended** |
| | **September 30,** | **September 30,** |
| | **2025** | **2024** |
|  | ***(in thousands)*** | ***(in thousands)*** |
| Cash provided by (used in): |  |  |
| &nbsp;&nbsp;Operating activities | $**23211** | $44830 |
| &nbsp;&nbsp;Investing activities | **(2395)** | (59224) |
| &nbsp;&nbsp;Financing activities | **(22950)** | (26630) |

---

Operating cash flows are subject to variability period over period as a result of the timing of payments related to accounts receivable, accounts payable, and other working capital items. Net cash provided by operating activities was $23.2 million and $44.8 million for the three months ended September 30, 2025 and September 30, 2024, respectively. Cash provided by operating activities for the three months ended September 30, 2025 is primarily attributable to net income and changes in working capital balances. Compared to September 30, 2024, accounts receivable and accounts payable decreased 1.8% and 8.5% respectively, while inventory increased 0.3%.

The number of days sales outstanding ("DSO") was 68 days at September 30, 2025, compared to 70 days at June 30, 2025 and 66 days at September 30, 2024. Inventory turned 5.1 times during the quarter ended September 30, 2025, compared to 5.9 times during the quarter ended June 30, 2025 and 5.3 times in the prior-year quarter ended September 30, 2024.

Cash used in investing activities for the three months ended September 30, 2025 was $2.4 million, compared to cash used by investing activities of $59.2 million in the prior-year period. Cash used in investing activities for the three months ended September 30, 2025 is due to capital expenditures. Cash used by investing activities for the three months ended September 30, 2024 represents cash paid for acquisitions and capital expenditures.

Management expects capital expenditures for fiscal year 2026 to range from $10.0 million to $15.0 million, primarily for IT and warehouse investments.

For the three months ended September 30, 2025 and September 30, 2024, cash used in financing activities totaled $23.0 million and $26.6 million, respectively. Cash used in financing activities for the three months ended September 30, 2025 and September 30, 2024 is primarily attributable to common stock repurchases.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

***Credit Facility***

We have a multi-currency senior secured credit facility with JPMorgan Chase Bank N.A., as administrative agent, and a syndicate of banks (as amended, the "Amended Credit Agreement"). On September 28, 2022, we amended and restated our Amended Credit Agreement, which includes (i) a five-year, $350 million multicurrency senior secured revolving credit facility and (ii) a five-year $150 million senior secured term loan facility. The Amended Credit Agreement extended the credit facility maturity date to September 28, 2027. In addition, pursuant to an "accordion feature," we may increase our borrowing limits up to an additional $250 million, subject to obtaining additional credit commitments from the lenders participating in the increase. The Amended Credit Agreement allows for the issuance of up to $50 million for letters of credit. Borrowings under the Amended Credit Agreement are guaranteed by substantially all of our domestic subsidiaries and secured by substantially all of our domestic assets. Under the terms of the revolving credit facility, the payment of cash dividends is restricted. We incurred debt issuance costs of $1.4 million in connection with the amendment and restatement of the Amended Credit Agreement. These costs were capitalized to other non-current assets on the Condensed Consolidated Balance Sheets and added to the unamortized debt issuance costs from the previous credit facility.

Loans denominated in U.S. dollars, other than swingline loans, bear interest at a rate per annum equal to, at our option, (i) the adjusted term SOFR or adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon our ratio of (A) total consolidated debt less up to $30 million of unrestricted domestic cash to (B) trailing four-quarter consolidated EBITDA measured as of the end of the most recent year or quarter, as applicable, for which financial statements have been delivered to the Lenders (the "leverage ratio"); or (ii) the alternate base rate plus an additional margin ranging from 0% to 0.75%, depending upon our leverage ratio, plus, if applicable, certain mandatory costs. All swingline loans denominated in U.S. dollars bear interest based upon the adjusted daily simple SOFR plus an additional margin ranging from 1.00% to 1.75% depending upon our leverage ratio, or such other rate as agreed upon with the applicable swingline lender. The adjusted term SOFR and adjusted daily simple SOFR include a fixed credit adjustment of 0.10% over the applicable SOFR reference rate. Loans denominated in foreign currencies bear interest at a rate per annum equal to the applicable benchmark rate set forth in the Amended Credit Agreement plus an additional margin ranging from 1.00% to 1.75%, depending upon our leverage ratio plus, if applicable, certain mandatory costs.

During the quarter ended September 30, 2025, our borrowings under the Amended Credit Agreement were U.S. dollar loans. The spread in effect as of September 30, 2025 was 1.00% for SOFR-based loans and 0.00% for alternate base rate loans. The commitment fee rate in effect at September 30, 2025 was 0.15%. The Amended Credit Agreement includes customary representations, warranties and affirmative and negative covenants, including financial covenants. Specifically, our Leverage Ratio must be less than or equal to 3.50 to 1.00 at all times. In addition, our Interest Coverage Ratio (as such term is defined in the Amended Credit Agreement) must be at least 3.00 to 1.00 at the end of each fiscal quarter. In the event of a default, customary remedies are available to the lenders, including acceleration and increased interest rates. We were in compliance with all covenants under the credit facility at September 30, 2025.

The average daily outstanding balance on the revolving credit facility, excluding the term loan facility, during the three month periods ended September 30, 2025 and 2024 was $1.1 million and $0.1 million, respectively. There was $350.0 million available for additional borrowings as of September 30, 2025 and June 30, 2025, respectively. The effective interest rates for the revolving line of credit were 5.28% and 5.46% as of September 30, 2025 and June 30, 2025, respectively. There were no letters of credit issued under the multi-currency revolving credit facility at September 30, 2025 or June 30, 2025. Availability to use this borrowing capacity depends upon, among other things, the levels of our Leverage Ratio and Interest Coverage Ratio, which, in turn, will depend upon (1) our Credit Facility Net Debt relative to our Credit Facility EBITDA and (2) Credit Facility EBITDA relative to total interest expense, respectively. As a result, our availability will increase if EBITDA increases (subject to the limit of the facility) and decrease if EBITDA decreases. While we were in compliance with the financial covenants contained in the Amended Credit Agreement as of September 30, 2025, and currently expect to continue to maintain such compliance, should we encounter difficulties, our historical relationship with our Amended Credit Agreement lending group has been strong and we anticipate their continued support of our long-term business.

***Summary***

We believe that our existing sources of liquidity, including cash resources and cash provided by operating activities, supplemented as necessary with funds under our credit agreements, will provide sufficient resources to meet our present and future working capital and cash requirements for at least the next twelve months. We also believe that our longer-term working capital, planned expenditures and other general funding requirements will be satisfied through cash flows from operations and, to the extent necessary, from our borrowing facilities.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**Accounting Standards Recently Issued**

See Note 1 of the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the anticipated dates of adoption and the effects on our consolidated financial position and results of operations.

**Critical Accounting Policies and Estimates**

Critical accounting policies are those that are important to our financial condition and require management's most difficult, subjective or complex judgments. Different amounts would be reported under different operating conditions or under alternative assumptions. See Management's Discussion and Analysis of Financial Condition and Results from Operations in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 for a complete discussion.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | |
|:---|:---|
| **Item 3.** | **Quantitative and Qualitative Disclosures About Market Risk** |

---

For a description of our market risks, see Part II, Item 7A. "Quantitative and Qualitative Disclosures About Market Risk" in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025. No material changes have occurred to our market risks since June 30, 2025.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | |
|:---|:---|
| **Item 4.** | **Controls and Procedures** |

---

An evaluation was carried out under the supervision and with the participation of our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") of the effectiveness of our disclosure controls and procedures at September 30, 2025. Based on that evaluation, our management, including the CEO and CFO, concluded that our disclosure controls and procedures are effective at September 30, 2025. During the quarter ended September 30, 2025, there was no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**PART II. OTHER INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Legal Proceedings** |

---

The Company is, from time to time, party to lawsuits arising out of operations. Although there can be no assurance, based upon information known to us, we believe that any liability resulting from an adverse determination of such lawsuits would not have a material adverse effect on our financial condition or results of operations. For a description of our material legal proceedings, see Note 12 - *Commitments and Contingencies* in the notes to the condensed consolidated financial statements, which is incorporated herein by reference.

---

| | |
|:---|:---|
| **Item 1A.** | **Risk Factors** |

---

In addition to the risk factors discussed in our other reports and statements that we file with the SEC, you should carefully consider the factors discussed in Part I, Item 1A. "Risk Factors" in our Annual Report on Form 10-K for the year ended June 30, 2025, which could materially affect our business, financial condition and/or future operating results.

There have been no material changes to the risk factors disclosed in Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2025.

---

| | |
|:---|:---|
| **Item 2.** | **Unregistered Sales of Equity Securities and Use of Proceeds** |

---

*Share Repurchases*

In April 2025, our Board of Directors approved a $200.0 million share repurchase authorization. The authorization does not have any time limit.

The following table presents the share-repurchase activity for the quarter ended September 30, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total number of shares purchased** <sup>(1)</sup> | **Average price paid per share** | **Total number of shares purchased as part of the publicly announced plan or program** | **Approximate dollar value of shares that may yet be purchased under the plan or program** |
| July 1 - 31, 2025 | 215413 | $41.35 | 215413 | $208152820 |
| August 1 - 31, 2025 | 265660 | $42.11 | 207463 | $199416354 |
| September 1 - 30, 2025 | 68134 | $44.16 | 66861 | $196463926 |
| Total | 549207 |  | 489737 | $196463926 |

---

<sup>(1)</sup> Shares withheld from employees' stock-based awards to satisfy required tax withholding obligations totaled 58,197 for the month of August 2025 and 1,273 for the month of September 2025. There were no shares withheld during the month of July 2025.

*Dividends*

We have never declared or paid a cash dividend. Under the terms of our credit facility, the payment of cash dividends is restricted.

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | |
|:---|:---|
| **Item 5.** | **Other Information** |

---

During the three months ended September 30, 2025, none of our directors or our officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933).

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

---

| | |
|:---|:---|
| **Item 6.** | **Exhibits** |

---

---

| | |
|:---|:---|
| **<u>Exhibit<br>Number</u>** | **<u>Description</u>** |
| 10.1 (a) | <u>[Form of Performance-Based Restricted Stock Unit Award Certificate (Performance- and Service-Based) under the 2024 Omnibus Incentive Compensation Plan](scansourceex101psucertif.htm)</u> |
| 10.2 (a) | <u>[Form of Director Restricted Stock Unit Award Certificate under the 2024 Omnibus Incentive Compensation Plan](scansourceex102directorc.htm)</u> |
| 31.1 (a) | <u>[Certification of the Chief Executive Officer, Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](scansourceex311q1fy26.htm)</u> |
| 31.2 (a) | <u>[Certification of the Chief Financial Officer, Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](scansourceex312q1fy26.htm)</u> |
| 32.1 (b) | <u>[Certification of the Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](scansourceex321q1fy26.htm)</u> |
| 32.2 (b) | <u>[Certification of the Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](scansourceex322q1fy26.htm)</u> |
| 101 (a) | The following materials from our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets at September 30, 2025 and June 30, 2025; (ii) the Condensed Consolidated Income Statements for the quarters ended September 30, 2025 and 2024; (iii) the Condensed Consolidated Statements of Comprehensive Income for the quarters ended September 30, 2025 and 2024; (iv) the Condensed Consolidated Statements of Shareholder's Equity for the quarters ended September 30, 2025 and 2024; (v) the Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2025 and 2024; and (vi) the Notes to the Condensed Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL |
| 104 (a) | Cover page Inline XBRL File (Included in Exhibit 101) |
| (a) | Filed herewith |
| (b) | Furnished herewith |

---

------

<u>[**Table of Contents**](#i46704b41bb0b4774b71bf1ae9cea5ff2_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | | ScanSource, Inc. |
| Date: | November 6, 2025 | /s/ MICHAEL L. BAUR |
| | | Michael L. Baur |
| | | Chair, President and Chief Executive Officer<br>(Principal Executive Officer) |

---

---

| | | |
|:---|:---|:---|
| Date: | November 6, 2025 | /s/ STEVE JONES |
| | | Steve Jones |
| | | Senior Executive Vice President and Chief Financial Officer (Principal Financial Officer) |

---

---

| | | |
|:---|:---|:---|
| Date: | November 6, 2025 | /s/ BRANDY FORD |
| | | Brandy Ford |
| | | Senior Vice President and Chief Accounting Officer (Principal Accounting Officer) |

---

## Exhibit 10.1

![](scansourceex101psucertif001.jpg)

Exhibit 10.1 FORM OF PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD CERTIFICATE (Performance- and Service-Based) Non-transferable GRANT TO _____________________ (the "Participant") by ScanSource, Inc. (the "Company") The Company hereby grants to Participant a performance-based and service-based Restricted Stock Unit ("PSU") Award (the "Award"), which represents a contingent right to acquire shares of the Company's common stock (the "Common Stock"), no par value per share (the "Shares"). The Award is subject to the terms and conditions set forth in this certificate (the "Award Certificate"), including Schedule A, which is attached hereto and expressly made a part of this Agreement, and the ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan, as it may be amended and/or restated (the "Plan"), the terms of which are incorporated herein in their entirety. Participant: ___________________ Grant Date: ___________________ Service Requirement: Grant Date to [the third anniversary thereof] Performance Cycle: July 1, 20__ to June 30, 20__ The actual number of Shares, if any, subject to the Award that may be earned shall be determined based on the attainment of the performance goals specified in Schedule A, as determined by the Compensation Committee (the "Committee") following the end of the Performance Cycle; provided, however, that no Shares shall vest and be distributable to the Participant unless the Participant is continuously employed by the Company through the end of the Service Requirement and the provisions of Section 2 of Schedule A are met, except as otherwise provided in Section 3 of the Award Certificate in the event of death, Disability or Retirement or in Section 4 of the Award Certificate in the event of a Change in Control. Number of Performance-Based Restricted Stock Units: The aggregate target number of PSUs for the Performance Cycle is ______ PSUs (the "Target PSUs"). The maximum number of PSUs that are eligible to be earned under the Award is between 0% and 200% of the Target PSUs as set forth in Schedule A.

------

![](scansourceex101psucertif002.jpg)

Exhibit 10.1 IN WITNESS WHEREOF, the Company, acting by and through its duly authorized officers, has caused the Award Certificate to be executed effective as of the Grant Date. SCANSOURCE, INC. By: Its: Authorized Officer Grant Date:

------

![](scansourceex101psucertif003.jpg)

Exhibit 10.1 AWARD CERTIFICATE TERMS AND CONDITIONS 1. Grant of Award. The Company hereby grants to the Participant, subject to the restrictions and the other terms and conditions set forth in the Plan and the Award Certificate, the number of Shares indicated on Schedule A hereto. For the purposes herein, the Shares subject to the Award are units that will be reflected in a book account maintained by the Company and that will be settled in shares of Common Stock if and only to the extent permitted under the Plan and the Award Certificate. Prior to issuance of any Shares upon vesting and payment of the Award, the Award shall represent an unsecured obligation of the Company, payable (if at all) only from the Company's general assets. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Plan. 2. Vesting and Earning of the Award. The number of Shares subject to the Award that may be earned during the Performance Cycle will be determined by the Committee following the end of the Performance Cycle, as provided in Schedule A; provided, however, that (except as otherwise provided in Section 3 or Section 4 below), the Award shall not vest, in whole or in part, and the Participant shall not be entitled to any of the Shares (that is, Shares subject to the Award shall remain subject to forfeiture), unless the Participant remains continuously employed by the Company from the Grant Date until the end of the Service Requirement. The Committee has sole discretion to determine if and the extent to which the Award has become earned and vested. One Share of Common Stock will be issuable for each PSU that is earned and vests. PSUs that have been earned and become vested are referred to herein as "Vested PSUs." PSUs that have not become earned and vested and remain subject to forfeiture are referred to herein as "Unvested PSUs". The Unvested PSUs and Vested PSUs are collectively referred to herein as the "PSUs". The Award will terminate and the Unvested PSUs will be subject to forfeiture upon termination of the Participant's employment as set forth in Section 3. 3. Effect of Termination; Forfeiture. (a) If the Participant's employment with the Company terminates for any reason prior to June 30, 20__ other than as set forth in Section 3(b) or Section 4 below, then the Participant shall forfeit all of the Participant's right, title and interest in the Award (and the underlying Shares), to the extent not vested and earned as of the date of the Participant's termination of employment, and such Unvested PSUs shall revert to the Company (without the payment by the Company of any consideration for such Shares) immediately following the event of forfeiture. (b) Notwithstanding the provisions of Section 2, Schedule A and Section 3(a) herein, the Award shall be deemed earned and vested on the earliest to occur of the following: (i) Upon the termination of the Participant's employment due to death or Disability prior to the end of the Service Requirement, (A) the Award shall be deemed earned as if the goal(s) for the Performance Cycle had been met at target and the earned PSUs will vest as of the termination of the Participant's employment with the Company due to death or Disability, if the termination of the Participant's employment occurs prior to completion of the Performance Cycle, or (B) the Award shall vest, with respect to the previously-earned PSUs, as of the termination of the Participant's employment with the Company due to death or Disability, if the termination of the Participant's employment occurs after completion of the Performance Cycle.

------

![](scansourceex101psucertif004.jpg)

Exhibit 10.1 (ii) Upon the termination of the Participant's employment due to Retirement prior to the end of the Service Requirement, the Participant shall be paid a pro rata award based on the number of completed days in service from the Grant Date until the end of the Service Requirement, (A) based on actual performance through the date of termination of the Participant's employment, if the termination of the Participant's employment occurs prior to completion of the Performance Cycle, or (B) with respect to previously-earned PSUs, if the termination of the Participant's employment occurs after completion of the Performance Cycle. (c) Any amounts payable as provided herein shall be paid as described in Section 6. (d) "Cause" shall have the meaning given such term in the Plan, "Disability" shall have the meaning given such term in the Plan; and "Retirement" shall mean the meaning set forth in the Company's Executive Severance Plan, as it may be amended and/or restated, (the "Executive Severance Plan"); provided, however, that, if on the Grant Date, the Participant is not a participant in the Executive Severance Plan, the meaning shall be the occurrence of both (i) the Participant's Termination of Service (other than for Cause) on or after the date that Participant's age plus years of employment with the Company and its Affiliates equals or exceeds sixty-five (65), and (ii) the Committee's determination that the Participant's termination qualifies as a retirement that is not in connection with a pending involuntary termination, including any notification of inclusion in a reduction in force, and, provided that, if the Committee has not made a determination within thirty (30) days of the Participant's Termination of Service, the Participant's termination shall be deemed to qualify as a retirement. For purposes of the Award, termination of employment will be construed consistent with a separation from service within the meaning of Section 409A of the Code. 4. Effect of Change in Control. In the event of a Change in Control prior to the end of the Service Requirement: (a) To the extent that the successor or surviving company in the Change in Control event does not assume or substitute for the Award (or in which the Company is the ultimate parent corporation and does not continue the Award) on substantially similar terms or with substantially equivalent economic benefits (as determined by the Committee) as Awards outstanding under the Plan immediately prior to the Change in Control event, the Award shall be deemed vested, earned and payable (A) based on attainment of the performance goal(s) at target with respect to the Performance Cycle that has not been completed as of the date of the Change in Control or (B) with respect to previously earned PSUs if the Performance Cycle has been completed by the time of the date of the Change in Control, provided the Participant remains continuously employed by the Company from the Grant Date until the time of the Change in Control. (b) The Award will nonetheless become vested, earned and payable as provided herein if the employment of the Participant is terminated by the Company or the Participant in contemplation of a Change in Control (whether or not the Change in Control is consummated) or, in the event that the Award is substituted, assumed or continued in connection with a Change in Control, within one year after the effective date of a Change in Control, in either event prior to the end of the Service Requirement, if such termination of employment (X) is by the Company not for Cause or (Y) is by the Participant for Good Reason. In such event, the Award shall be deemed vested, earned and payable (i) (A) based on actual performance through the date of termination of the Participant's employment if the employment of the Participant is terminated by the Company or the Participant

------

![](scansourceex101psucertif005.jpg)

Exhibit 10.1 in contemplation of a Change in Control (whether or not the Change in Control is consummated) and prior to completion of the Performance Cycle, or (B) with respect to previously-earned PSUs, if the employment of the Participant is terminated by the Company or the Participant in contemplation of a Change in Control (whether or not the Change in Control is consummated) and after completion of the Performance Cycle, and (ii) (A) as if the performance goal(s) had been met at target with respect to the Performance Cycle that has not been completed as of the date of the Change in Control if the employment of the Participant is terminated by the Company or the Participant within one year after the effective date of a Change in Control or (B) with respect to previously-earned PSUs with respect to the Performance Cycle that has been completed as of the date of the Change in Control if the employment of the Participant is terminated by the Company or the Participant within one year after the effective date of the Change in Control. The employment of the Participant will be deemed to have been terminated in contemplation of a Change in Control if the Participant's employment terminates at any time during which (i) the Company has initiated a transaction process or is engaged in discussions with a third party about a specific transaction that, if consummated, would result in a Change in Control (and before complete abandonment of such discussions without the transaction being consummated) or (ii) the Company has become a party to a definitive agreement to consummate a transaction that would result in a Change in Control (and before complete termination of such agreement without the transaction being consummated). (c) Any amounts payable as provided herein shall be paid as described in Section 6. (d) "Change in Control" shall have the meaning given such term in the Plan, and "Good Reason" shall has the same definition as under any employment, change in control or service agreement between the Company or any Affiliate and the Participant or, if no such employment, change in control or service agreement exists or if such employment, change in control or service agreement does not contain any such definition, "Good Reason" shall mean, without the Participant's consent, the following: (i) any action taken by the Company or an Affiliate which results in a material reduction in the Participant's authority, duties or responsibilities (except that any change in the foregoing that results solely from (A) the Company ceasing to be a publicly traded entity or from the Company becoming a wholly-owned subsidiary of another publicly traded entity or (B) any change in the geographic scope of the Participant's authority, duties or responsibilities will not, in any event and standing alone, constitute a substantial reduction in the Participant's authority, duties or responsibilities); (ii) the assignment to the Participant of duties that are materially inconsistent with Participant's authority, duties or responsibilities; (iii) any material decrease in the Participant's base salary or annual bonus opportunity, except to the extent the Company has instituted a salary or bonus reduction generally applicable to all similar employees of the Company other than in contemplation of or after a Change in Control; (iv) other than for international employees, the relocation of the Participant to any principal place of employment other than that as of the date of grant of the Award, or any requirement that Participant relocate his or her residence other than to that as of the date of grant of the Award, without the Participant's express written consent to either such relocation, which in either event would increase the Participant's commute by more than fifty (50) miles; provided, however, this subsection (iv) shall not apply in the case of business travel which requires the Participant to relocate temporarily for periods of ninety (90) days or less; or (v) the failure by the Company to pay to the Participant any portion of the Participant's base salary or annual bonus within thirty (30) days after the date the same is due. Notwithstanding the above, and without limitation, Good Reason shall not include any resignation

------

![](scansourceex101psucertif006.jpg)

Exhibit 10.1 by the Participant where Cause for the Participant's termination by the Company or an Affiliate exists. The Participant must give the Company or an Affiliate that employs the Participant notice of any event or condition that would constitute Good Reason within thirty (30) days of the event or condition which would constitute Good Reason, and, upon the receipt of such notice, the Company or an Affiliate that employs the Participant shall have thirty (30) days to remedy such event or condition. If such event or condition is not remedied within such thirty (30) day period, any termination of employment by the Participant for Good Reason must occur within thirty (30) days after the period for remedying such condition or event has expired. 5. Restrictions; Forfeiture. In addition to other terms and conditions stated in the Plan or the Award Certificate, the Award and the underlying Shares are subject to the following restrictions. No right or interest of the Participant in the Award, to the extent restricted, may be pledged, encumbered or hypothecated to or in favor of any party other than the Company or an Affiliate or shall be subject to any lien, obligation or liability of the Participant to any other party other than the Company or an Affiliate. Except as otherwise provided in the Plan, the Award shall not be transferable (including by sale, assignment, pledge or hypothecation) other than by will or the laws of intestate succession. Prior to vesting and payment, the Shares subject to the Award may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise encumbered. Except as may be otherwise provided in the Plan or the Award Certificate, if the Participant's employment with the Company terminates for any reason (whether by the Company or the Participant and whether voluntary or involuntary) prior to the end of the Service Requirement other than as set forth in Section 3(b) or Section 4 herein, then the Participant shall forfeit all of the Participant's right, title and interest in and to the Award and the Shares to the extent the Award (and corresponding Shares) were not earned and vested as of the date the Participant's status as a Participant terminated. The restrictions imposed under this Section 5 shall apply to all Shares or other securities issued with respect to Shares hereunder in connection with any merger, reorganization, consolidation, recapitalization, stock dividend or other change in corporate structure affecting the Common Stock. 6. Settlement of Award; Delivery of Shares. No certificate or certificates for the Shares shall be issued at the time of grant of the Award. A certificate or certificates for the Shares underlying the Award (or, in the case of uncertificated Shares, other written evidence of ownership in accordance with applicable laws) shall be issued in the name of the Participant (or his beneficiary) only in the event, and to the extent, that the Award has been earned and vested. Notwithstanding the foregoing, the following provisions shall apply: (a) except with respect to distributions following termination of employment (that is, a "separation of service" under Code Section 409A) due to death, Disability or Retirement or in contemplation of a Change in Control or within one year after the effective date of a Change in Control, any Shares or other benefits payable pursuant to the Award shall, upon the earning and vesting of the Award, be distributed to the Participant (or his beneficiary) after the end of the Service Requirement and within the sixty (60) days following the end of the Service Requirement, and upon the earning and/or vesting of the Award in connection with a Change in Control be distributed to the Participant (or his beneficiary) within the sixty (60) days following the Change in Control; and (b) any distributions due to termination of employment as a result of death, Disability or Retirement or in contemplation of a Change in Control or within one (1) year after the effective date of a Change in Control shall be paid within sixty (60) days following the date of termination of employment (except as otherwise provided below with respect to a delay in payments if the Participant is a "specified employee"), and the Participant shall not

------

![](scansourceex101psucertif007.jpg)

Exhibit 10.1 have the right to designate the taxable year of the payment. Notwithstanding the foregoing, if the Participant is or may be a "specified employee" (as defined under Code Section 409A), and the distribution is due to separation from service, then such distribution shall be subject to delay as provided in Section 15.3 of the Plan (or any successor provision thereto). Notwithstanding the foregoing or anything herein to the contrary, the Committee, in its sole discretion and without the Participant's consent, retains the right to provide for settlement of the Award in cash, in lieu of delivery of Shares, as provided in Section 3.2 of the Plan (or any successor provision thereto). 7. Voting and Dividend Rights. The Participant shall not be deemed to be the holder of any underlying Shares of the Award and shall not have any dividend rights, voting rights or other rights as a shareholder unless and until (and only to the extent that) the Award has become earned and vested and certificates for such Shares have been issued to him (or, in the case of uncertificated shares, other written evidence of ownership in accordance with applicable laws shall have been provided). 8. No Right of Continued Employment or to Future Awards. Nothing in the Award Certificate shall interfere with or limit in any way the right of the Company or any Affiliate to terminate the Participant's employment at any time, nor confer upon the Participant any right to continue in the employ of the Company or any Affiliate. The grant of the Award does not create any obligation to grant further awards. 9. Tax Matters. The Participant will, no later than the date as of which any amount related to the Shares first becomes includable in the Participant's gross income for federal income tax purposes, pay to the Company, or make other arrangements satisfactory to the Committee regarding payment of, any federal, state, local and foreign taxes (including any Federal Insurance Contributions Act taxes) required by law to be withheld with respect to such amount. The withholding requirement may be satisfied, in whole or in part, unless the Committee determines otherwise, by withholding from the Award Shares having a Fair Market Value on the date of withholding equal to the minimum amount (and not any greater amount) required to be withheld for tax purposes, all in accordance with such procedures as the Committee establishes. The obligations of the Company under the Award Certificate will be conditional on such payment or arrangements, and the Company, or, where applicable, its Affiliates, will, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the Participant. The Participant acknowledges that the Company has made no warranties or representations to the Participant with respect to the legal, tax or investment consequences (including but not limited to income tax consequences) related to the grant of the Award or receipt or disposition of the Shares (or any other benefit), and the Participant is in no manner relying on the Company or its representatives for legal, tax or investment advice related to the Award or the Shares. The Participant acknowledges that there may be adverse tax consequences upon the grant of the Award and/or the acquisition or disposition of the Shares (or other benefit) subject to the Award and that the Participant has been advised to consult with their own attorney, accountant and/or tax advisor regarding the transactions contemplated by the Award and the Award Certificate. The Participant also acknowledges that the Company has no responsibility to take or refrain from taking any actions in order to achieve a certain tax result for the Participant. 10. Plan Controls; Entire Agreement; Amendment. The terms contained in the Plan are incorporated into and made a part of the Award Certificate and the Award Certificate shall be

------

![](scansourceex101psucertif008.jpg)

Exhibit 10.1 governed by and construed in accordance with the Plan. In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of the Award Certificate, the provisions of the Plan shall be controlling and determinative (unless the Committee determines otherwise). The Award Certificate, including Schedule A attached hereto, sets forth all of the promises, agreements, understandings, warranties and representations between the parties with respect to the Award. The Award Certificate may be amended as provided in the Plan. 11. Successors. The Award Certificate shall be binding upon any successor of the Company, in accordance with the terms of the Award Certificate and the Plan. 12. Severability. If any one or more of the provisions contained in the Award Certificate is held to be invalid, illegal or unenforceable, the other provisions of the Award Certificate will be construed and enforced as if the invalid, illegal or unenforceable provision had never been included. 13. Notice. Notices and communications under the Award Certificate must be in writing and either personally delivered or sent by registered or certified United States mail, return receipt requested, postage prepaid. Notices to the Company must be addressed to ScanSource, Inc., 6 Logue Court, Greenville, SC 29615, Attn: Secretary, or any other address designated by the Company in a written notice to the Participant. Notices to the Participant will be directed to the address of the Participant then currently on file with the Company, or at any other address given by the Participant in a written notice to the Company. 14. Beneficiary Designation. The Participant may, in the manner determined by the Committee, designate a beneficiary to exercise the rights of the Participant hereunder and to receive any distribution with respect to the Award upon the Participant's death. A beneficiary, legal guardian, legal representative, or other person claiming any rights hereunder is subject to all terms and conditions of the Award Certificate and the Plan and to any additional restrictions deemed necessary or appropriate by the Committee. If no beneficiary has been designated or survives the Participant, the Participant's rights with respect to the Award may be exercised by the legal representative of the Participant's estate, and payment shall be made to the Participant's estate. Subject to the foregoing, a beneficiary designation may be changed or revoked by the Participant at any time provided the change or revocation is filed with the Company. 15. Compliance with Recoupment, Ownership and Other Policies or Agreements. As a condition to receiving the Award, the Participant agrees to abide by all provisions of the Company's Stock Ownership and Retention Policy, Compensation Recovery Policy and/or other similar policies maintained by the Company, each as in effect from time to time and to the extent applicable to Participant from time to time. In addition, the Participant shall be subject to such compensation recovery, recoupment, forfeiture, or other similar provisions as may apply at any time to the Participant under Applicable Law.

------

![](scansourceex101psucertif009.jpg)

Exhibit 10.1 SCHEDULE A SCANSOURCE, INC. 2024 OMNIBUS INCENTIVE COMPENSATION PLAN Performance-Based Restricted Stock Unit Award Certificate (Performance-and Service-Based) This Schedule A sets forth the performance goals for the performance-based and service-based Restricted Stock Unit Award (the "Award") under the ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan, as it may be amended and/or restated (the "Plan"), evidenced by the Performance-Based Restricted Stock Unit Award Certificate (Performance- and Service-Based) (the "Award Certificate") to which it is attached. Capitalized terms not expressly defined in this Schedule A but defined in the Plan or the Award Certificate shall have the same definitions as in the Plan and/or the Award Certificate, as applicable. 1. Target PSUs: The aggregate target number of PSUs for the Performance Cycle is: _____ PSUs (the "Target PSUs"). The maximum number of PSUs that are eligible to be earned under the Award is between 0% and 200% of the Target PSUs. 2. Applicable Performance Goals; Number of PSUs Earned: The actual number of PSUs, if any, that shall be earned is based on the following formula: The actual number of PSUs earned equals the sum (rounded down to the nearest whole share) of (i) the aggregate target number of the PSUs for the Performance Cycle multiplied by 50% of the "Normalized EPS Achievement" (as described below) and (ii) the aggregate target number of the PSUs for the Performance Cycle multiplied by 50% of the "Adjusted ROIC Achievement" (as described below); the total sum capped at no more than 200% of the aggregate target number of PSUs for the Performance Cycle. 3. Determination of Normalized EPS Achievement: The Normalized EPS Achievement will be determined from the charts below based on the Normalized EPS achieved during the Performance Cycle. To determine the Normalized EPS Achievement, calculate the Normalized EPS percentage payout achieved for each of the fiscal years within the Performance Cycle. If the Normalized EPS for the fiscal year is below threshold, then the percentage payout will be zero (0). If the Normalized EPS for the fiscal year is at threshold, then the percentage payout will be 30%. If the Normalized EPS for the fiscal year is at target, then the percentage payout will be 100%. If the Normalized EPS for the fiscal year is at or above maximum, then the percentage payout will be 200%. For Normalized EPS results between (i) threshold and target and (ii) target and maximum, the percentage payout will be calculated using interpolation. The percentage payouts for each fiscal year during the performance period will be averaged to determine Normalized EPS Achievement. For example, if the Normalized EPS achieved for the first, second and third fiscal years are at target, threshold, and target respectively, then the Normalized EPS Achievement will be 76.67%, which is the average of 100%, 30%, and 100%. The Normalized EPS Achievement may not exceed 200%.

------

![](scansourceex101psucertif010.jpg)

Exhibit 10.1 Normalized EPS PSU Performance Metrics Threshold (30% Payout) Target (100% Payout) Maximum (200% Payout) Year 1 Year 2 Year 3 4. Determination of Adjusted ROIC Achievement. The Adjusted ROIC Achievement will be determined from the chart below based on the Adjusted ROIC achieved each year during the Performance Cycle. To determine the Adjusted ROIC Achievement, calculate the Adjusted ROIC percentage payout achieved for each of the fiscal years within the Performance Cycle. If Adjusted ROIC is below threshold, then the percentage payout will be zero (0). If Adjusted ROIC is at threshold, then the percentage payout will be 50%. If Adjusted ROIC is at target, then the percentage payout will be 100%. If Adjusted ROIC is at or above maximum, then the percentage payout will be 200%. For Adjusted ROIC results between (i) threshold and target and (ii) target and maximum, the percentage payout will be calculated using interpolation. The percentage payouts for each fiscal year during the performance period will be averaged to determine the Adjusted ROIC Achievement. For example, if the Adjusted ROIC achieved for the first, second and third fiscal years are below threshold, at target and above maximum respectively, then the Adjusted ROIC Achievement will be 100%, which is the average of 0%, 100% and 200%. The Adjusted ROIC Achievement may not exceed 200%. Adjusted ROIC PSU Performance Metrics Threshold (50% Payout) Target (100% Payout) Maximum (200% Payout) Year 1 Year 2 Year 3

------

![](scansourceex101psucertif011.jpg)

Exhibit 10.1 5. Committee Certification: Notwithstanding the foregoing, the Award shall not be deemed payable, in whole or in part, until the Committee's written certification regarding if and to the extent the applicable performance goals have been met. 6. Definitions: For purposes of this Schedule A, the following terms shall have the meanings set forth below: "Adjusted EBITDA" means the Company's adjusted earnings before interest expense, income taxes, depreciation, and amortization; the calculation starts with net income and adds back interest expense, income tax expense, depreciation expense, amortization of intangible assets, changes in fair value of contingent considerations, and other non-GAAP adjustments, including acquisition and divestiture costs, restructuring costs, cyberattack restoration costs, tax recovery, and non-cash share-based compensation expense. "Adjusted ROIC" means the Company's adjusted return on invested capital; the calculation equals Adjusted EBITDA divided by Invested Capital. "Invested Capital" means (i) the Company's average equity for the applicable period, determined by calculating the equity value as of the beginning and ending of the performance period plus acquisition and divestiture costs, restructuring costs (net of tax) and discontinued operations net loss, plus (ii) the Company's average daily funded interest-bearing debt for the applicable period. Average funded debt includes both continuing and discontinued operations and is calculated as the average daily amounts outstanding on the Company's short-term and long-term interest-bearing debt. "Normalized EPS" means the Company's aggregate earnings achieved for the fiscal year period adjusted to eliminate the effect of share buybacks, corporate tax rates, and mergers and acquisitions and normalized based on a Target Tax Rate divided by the weighted average number of shares outstanding as of June 30, 20__. "Target Tax Rate" means [the tax rate determined and approved by the Committee as of the Grant Date].

------

## Exhibit 10.2

![](scansourceex102directorc001.jpg)

Exhibit 10.2 FORM OF DIRECTOR RESTRICTED STOCK UNIT AWARD CERTIFICATE Non-transferable GRANT TO ________________________________ (the "Participant") by ScanSource, Inc. (the "Company") of the right to acquire ______________ shares of the Company's common stock (the "Common Stock"), no par value per share (the "Shares") pursuant to and subject to the provisions of the ScanSource, Inc. 2024 Omnibus Incentive Compensation Plan, as it may be amended and/or restated (the "Plan"), and to the terms and conditions set forth in this certificate (the "Award Certificate"). The Award Certificate describes the terms and conditions of the Restricted Stock Unit Award (the "Award") granted herein and constitutes an agreement between the Participant and the Company. Unless vesting is accelerated in accordance with the Plan or the Award Certificate, the vesting restrictions imposed under Section 2 of the Award Certificate will expire with respect to the Award and the underlying Shares subject to the Award on the twelve (12)-month anniversary of the Grant Date (as defined below), provided that the Participant has been continuously serving as a director of the Company as of the date hereof (the "Grant Date") until the vesting date. IN WITNESS WHEREOF, the Company, acting by and through its duly authorized officers, has caused the Award Certificate to be executed as of the Grant Date. SCANSOURCE, INC. By:_____________________________ Its: Authorized Officer Grant Date: ____________

------

![](scansourceex102directorc002.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;1 AWARD CERTIFICATE TERMS AND CONDITIONS Grant of Award. The Company hereby grants to the Participant , subject to the restrictions and the other terms and conditions set forth in the Plan and the Award for the number of Shares indicated on the first page hereof. For the purposes herein, the underlying Shares subject to the Award are units that will be reflected in a book account maintained by the Company and that will be settled in Shares if and only to the extent permitted under the Plan and the Award Certificate. Prior to issuance of any Shares upon vesting of the Award, the Award shall represent an unsecured obligation of the Company, payable (if at all) only from the Company's general assets. Capitalized terms used herein and not otherwise defined shall have the meanings assigned to such terms in the Plan. Restrictions; Forfeiture. The Award and the underlying Shares are subject to the following restrictions. No right or interest of the Participant in the Award, to the extent restricted, may be pledged, encumbered or hypothecated to or in favor of any party other than the Company or an Affiliate or shall be subject to any lien, obligation or liability of the Participant to any other party other than the Company or an Affiliate. Except as otherwise provided in the Plan, the Award shall not be transferable (including by sale, assignment, pledge or hypothecation) other than by will or the laws of intestate succession. Prior to vesting, the underlying Shares of the Award may not be sold, transferred, exchanged, assigned, pledged, hypothecated or otherwise encumbered. Except as may be otherwise provided in the Plan or the Award Certificate, if the Participant's service with the Company terminates for any reason other than as set forth in paragraphs (b) or (c) of Section 3 hereof, and unless the Board determines otherwise, then the Participant shall forfeit all of the Participant's right, title and interest in and to the Award and the underlying Shares to the extent the Award (and corresponding Shares) were not vested as of the date the Participant terminates service as a director of the Company due to a separation from service (as defined under Code Section 409A). The restrictions imposed under this section shall apply to all Shares or other securities issued with respect to Shares hereunder in connection with any merger, reorganization, consolidation, recapitalization, stock dividend or other change in corporate structure affecting the Common Stock. Expiration and Termination of Restrictions. The restrictions imposed under Section 2 will expire on the earliest to occur of the following (the period prior to such expiration being referred to herein as the "Restricted Period"): (a) As to all of the underlying Shares, on the twelve (12)-month anniversary of the Grant Date, provided the Participant is still in service as a director of the Company on such vesting date and has been in service since the Grant Date; or (b) As to all of the underlying Shares, upon the termination of the Participant's service as a director of the Company due to a separation from service (as defined under Code Section 409A) due to death, Disability or Retirement; or (c) As to all of the underlying Shares, in the event of a Change in Control (unless required otherwise by Section 409A of the Code), as follows:

------

![](scansourceex102directorc003.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;2 (i) To the extent that the successor or surviving company in the Change in Control event does not assume or substitute for the Award (or in which the Company is the ultimate parent corporation and does not continue the Award) on substantially similar terms or with substantially equivalent economic benefits (as determined by the Committee) as the Awards outstanding under the Plan immediately prior to the Change in Control event, any restrictions, including but not limited to the restriction period, applicable to the Award shall be deemed to have been met, and the Award shall become fully vested, earned and payable to the fullest extent of the original grant of the Award, provided the Participant is still in service as a director of the Company from the Grant Date until the time of the Change in Control. (ii) Further, the Award will nonetheless become vested in full if the Participant's service as a Director terminates other than by voluntary resignation by the Participant in contemplation of a Change in Control (whether or not the Change in Control is consummated) or, in the event that the Award is substituted, assumed or continued as provided in Section 3(c)(i) herein, within one (1) year after the effective date of a Change in Control. The service of the Participant as a director of the Company will be deemed to have been terminated in contemplation of a Change in Control if the Participant's service as a director of the Company terminates at any time during which (i) the Company has initiated a transaction process or is engaged in discussions with a third party about a specific transaction that, if consummated, would result in a Change in Control (and before complete abandonment of such discussions without the transaction being consummated) or (ii) the Company has become a party to a definitive agreement to consummate a transaction that would result in a Change in Control (and before complete termination of such agreement without the transaction being consummated). (d) For clarification, for the purposes of this Section 3, "Disability" shall have the meaning given such term in Section 2.26(c) of the Plan, and the Participant's Termination of Service will be deemed to be due to Retirement if and only if the Committee, in its sole and absolute discretion, determines, at the time of the Participant's Termination of Service, that the Participant terminated service as a director of the Company due to Retirement (and the Committee will not be required to deem the Participant's Termination of Service as due to Retirement even if similarly-situated directors previously were deemed to have terminated service as a director of the Company due to Retirement). Settlement of Award; Delivery of Shares. No certificate or certificates for the Shares shall be issued on the Grant Date. Except as otherwise set forth herein, a certificate or certificates for the underlying Shares (or, in the case of uncertificated Shares, other written evidence of ownership in accordance with applicable laws) shall be issued in the name of the Participant (or such Participant's beneficiary) only in the event, and to the extent, that the Award has vested. Notwithstanding the foregoing, the following provisions shall apply: (a) except as provided under Section 4(b) herein or to the extent otherwise required or permitted under Code Section 409A, any Shares or other benefits payable pursuant to the Award shall, upon vesting of the Award, be distributed to the Participant (or his beneficiary) within sixty (60) days after the vesting of the Award (provided that if such sixty (60)-day period begins in one (1) calendar year and ends in another, the Participant (or his beneficiaries) shall not have the right to designate the taxable year of payment; and (b) in the event that the Participant is a "specified employee" (as defined under

------

![](scansourceex102directorc004.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;3 Code Section 409A), and the distribution is due to separation from service, then such distribution shall be subject to delay as provided in Section 15.3 of the Plan (or any successor provision thereto). Voting and Dividend Rights. The Participant shall not be deemed to be the holder of any underlying Shares of the Award and shall not have any dividend rights, voting rights or other rights as a shareholder unless and until (and only to the extent that) the Award has vested and certificates for such Shares have been issued to him (or, in the case of uncertificated shares, other written evidence of ownership in accordance with applicable laws shall have been provided). No Right of Continued Service or to Future Awards. Nothing in the Award Certificate shall interfere with or limit in any way the right of the Company or its shareholders to terminate the Participant's service at any time, nor confer upon the Participant any right to continue in the service of the Company or any Affiliate. The grant of the Award does not create any obligation to grant further awards. Tax Matters. The Participant acknowledges that the Company has made no warranties or representations to the Participant with respect to the legal, tax or investment consequences (including but not limited to income tax consequences) related to the grant of the Award or receipt or disposition of the Shares (or any other benefit), and the Participant is in no manner relying on the Company or its representatives for legal, tax or investment advice related to the Award or the Shares. The Participant acknowledges that there may be adverse tax consequences upon the grant of the Award and/or the acquisition or disposition of the Shares (or other benefit) subject to the Award and that the Participant has been advised to consult with their own attorney, accountant and/or tax advisor regarding the transactions contemplated by the Award and the Award Certificate. The Participant also acknowledges that the Company has no responsibility to take or refrain from taking any actions in order to achieve a certain tax result for the Participant. Plan Controls; Entire Agreement; Amendment. The terms contained in the Plan are incorporated into and made a part of the Award Certificate and the Award Certificate shall be governed by and construed in accordance with the Plan. In the event of any actual or alleged conflict between the provisions of the Plan and the provisions of the Award Certificate, the provisions of the Plan shall be controlling and determinative (unless the Committee determines otherwise). The Award Certificate sets forth all of the promises, agreements, understandings, warranties and representations between the parties with respect to the Award. The Award Certificate may be amended as provided in the Plan. Successors. The Award Certificate shall be binding upon any successor of the Company, in accordance with the terms of the Award Certificate and the Plan. Severability. If any one or more of the provisions contained in the Award Certificate is held to be invalid, illegal or unenforceable, the other provisions of the Award Certificate will be construed and enforced as if the invalid, illegal or unenforceable provision had never been included. Notice. Notices and communications under the Award Certificate must be in writing and either personally delivered or sent by registered or certified United States mail, return receipt

------

![](scansourceex102directorc005.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;4 requested, postage prepaid. Notices to the Company must be addressed to ScanSource, Inc., 6 Logue Court, Greenville, SC 29615, Attn: Secretary, or any other address designated by the Company in a written notice to the Participant. Notices to the Participant will be directed to the address of the Participant then currently on file with the Company, or at any other address given by the Participant in a written notice to the Company. Beneficiary Designation. The Participant may, in the manner determined by the Committee, designate a beneficiary to exercise the rights of the Participant hereunder and to receive any distribution with respect to the Award upon the Participant's death. A beneficiary, legal guardian, legal representative or other person claiming any rights hereunder is subject to all terms and conditions of the Award Certificate and the Plan and to any additional restrictions deemed necessary or appropriate by the Committee. If no beneficiary has been designated or survives the Participant, the Participant's rights with respect to the Award may be exercised by the legal representative of the Participant's estate, and payment shall be made to the Participant's estate. Subject to the foregoing, a beneficiary designation may be changed or revoked by the Participant at any time provided the change or revocation is filed with the Company. Compliance with Recoupment, Ownership and Other Policies or Agreements. As a condition to receiving the Award, the Participant agrees to abide by all provisions of any equity retention policy, compensation recovery policy, stock ownership guidelines and/or other similar policies maintained by the Company, each as in effect from time to time and to the extent applicable to Participant from time to time. In addition, the Participant shall be subject to such compensation recovery, recoupment, forfeiture, or other similar provisions as may apply at any time to the Participant under Applicable Law. Deferral Rights. Notwithstanding any other provision of the Award Certificate, the Participant may elect to defer the receipt of any Shares that would otherwise be payable upon vesting of the Award. Any such deferral shall be subject to such terms and conditions as may be established pursuant to the plan under which such Shares will be deferred and to the extent permitted by Code Section 409A.

------

## Exhibit 31.1

**Exhibit 31.1** 

Certification Pursuant to Rule 13a-14(a) or 15d-14(a)

of the Exchange Act, as adopted Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

I, Michael L. Baur, certify that:

1. I have reviewed this quarterly report on Form 10-Q of ScanSource, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ MICHAEL L. BAUR |
| Michael L. Baur<br>Chair, President and Chief Executive Officer<br>(Principal Executive Officer) |

---

Date: November 6, 2025

## Exhibit 31.2

**Exhibit 31.2** 

Certification Pursuant to Rule 13a-14(a) or 15d-14(a)

of the Exchange Act, as adopted Pursuant to Section 302 of the

Sarbanes-Oxley Act of 2002

I, Steve Jones, certify that:

1. I have reviewed this quarterly report on Form 10-Q of ScanSource, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| |
|:---|
| /s/ STEVE JONES |
| Steve Jones<br>Senior Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer) |

---

Date: November 6, 2025

## Exhibit 32.1

**Exhibit 32.1**

Certification of the Chief Executive Officer of ScanSource, Inc.

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to § 906

of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of ScanSource, Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1)The Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"); and

2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | November 6, 2025 | /s/ MICHAEL L. BAUR |
| | | Michael L. Baur<br>Chair, President and Chief Executive Officer<br>(Principal Executive Officer) |

---

This certification is being furnished solely to comply with the provisions of § 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the accompanying Report, including for purposes of Section 18 of the Exchange Act, or as a separate disclosure document. A signed original of this written certification required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written certification required by Section 906, has been provided to the Company and will be rendered by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

**Exhibit 32.2** 

Certification of the Chief Financial Officer of ScanSource, Inc.

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to § 906

of the Sarbanes-Oxley Act of 2002

In connection with the quarterly report of ScanSource, Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned officer of the Company certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1)The Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"); and

2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| Date: | November 6, 2025 | /s/ STEVE JONES |
| | | Steve Jones<br>Senior Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer) |

---

This certification is being furnished solely to comply with the provisions of § 906 of the Sarbanes-Oxley Act of 2002 and is not being filed as part of the accompanying Report, including for purposes of Section 18 of the Exchange Act, or as a separate disclosure document. A signed original of this written certification required by Section 906, or other document authenticating, acknowledging or otherwise adopting the signature that appears in typed form within the electronic version of this written certification required by Section 906, has been provided to the Company and will be rendered by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

<br>